Persons encountering health services for examination and investigation

Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z00-Z13 Cause of death: ICD-10 — Z00-Z13 2 out of 7 registries used, show all original rules.	283104
4. Check minimum number of events None	283104
5. Include endpoints Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS Z21_OTHER_SPECIAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS Z21_EXAM_ENCOUNTER_ADMINISTR_PURPO Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI Z21_EXAM_OBSER_OTH_REASO Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS Z21_ROUTI_GENERAL_HEALTH_CHECK_DEFIN_SUBPO Z21_SPECIAL_SCREEN_EXAM_INFECTIOUS_PARASITIC_DISEA Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS Z21_SPECIAL_SCREEN_EXAM_OTH_DISEA_DISORD	283104
6. Filter based on genotype QC (FinnGen only)	272791

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z

NAME	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS\|Z21_OTHER_SPECIAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS\|Z21_EXAM_ENCOUNTER_ADMINISTR_PURPO\|Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI\|Z21_EXAM_OBSER_OTH_REASO\|Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS\|Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS\|Z21_ROUTI_GENERAL_HEALTH_CHECK_DEFIN_SUBPO\|Z21_SPECIAL_SCREEN_EXAM_INFECTIOUS_PARASITIC_DISEA\|Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS\|Z21_SPECIAL_SCREEN_EXAM_OTH_DISEA_DISORD
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z[0-1]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z[0-1]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Persons encountering health services for examination and investigation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	272791	167594	105197
Unadjusted period prevalence (%)	55.11	59.45	48.19
Median age at first event (years)	51.14	47.37	57.15

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
47190: Matched controls
236599

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.9

321.4

1871

3272

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

321.2

5903

17104

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

320.5

8542

27589

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

320.4

18068

69479

XCK00

NOMESCO Finland

Perimetry

3.0

320.3

1849

3217

A02BC03

ATC

lansoprazole; oral

1.6

318.9

9711

32467

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

318.2

7395

22992

KMAK, ,

NOMESCO Finland

1.5

316.2

19952

78426

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

313.0

28990

122818

C03CA01

ATC

furosemide; systemic

1.6

312.4

10082

34175

SPAT1301

SPAT

No procedures

1.6

308.9

11147

38800

N06AB04

ATC

citalopram; systemic

1.7

308.3

7158

22228

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

17.8

307.7

699

200

XQ800

NOMESCO Finland

Prick test

4.5

307.7

2654

3125

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

6.6

307.7

5661

4815

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

307.7

4301

10121

M79.6

ICD-10 Finland

Pain in limb

1.6

307.7

15330

53642

M25.5

ICD-10 Finland

Pain in joint

1.6

307.7

11271

38300

R51.80

ICD-10 Finland

Headache

2.2

307.7

5571

13818

L28

ICPC

Limited function/disability (L)

2.0

307.7

5582

15221

S18

ICPC

Laceration/cut

1.7

307.7

16719

58082

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

307.7

8114

24893

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

15885

57094

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

4.6

307.7

2157

2419

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

307.7

8129

24906

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

307.7

3319

6705

Z01.1

ICD-10 Finland

Examination of ears and hearing

9.8

307.7

6339

3682

A02BC02

ATC

pantoprazole; systemic

1.8

307.7

27244

101612

J01MA02

ATC

ciprofloxacin; systemic

1.6

307.7

14167

51086

L17

ICPC

Foot/toe symptom/complaint

1.6

307.7

9754

32457

N05BA04

ATC

oxazepam; oral

1.7

307.7

9358

29465

AA1AD

NOMESCO Finland

CT of head and brain

1.7

307.7

9200

28770

RD211, ,

NOMESCO Finland

4.1

307.7

1298

1618

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.6

307.7

3505

7002

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

307.7

15732

57595

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

16790

61336

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

14.0

307.7

5786

2331

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

307.7

6448

18188

R03AC02

ATC

salbutamol; inhalant

1.6

307.7

21569

82103

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

307.7

11147

25306

DFF00

NOMESCO Finland

Pure tone audiometry

4.2

307.7

3392

4242

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

4.5

307.7

2148

2479

Z97.4

ICD-10 Finland

Presence of external hearing-aid

5.6

307.7

1559

1432

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

25.4

307.7

3114

655

Z01.0

ICD-10 Finland

Examination of eyes and vision

19.9

307.7

8328

2522

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

307.7

11293

37561

N06AX11

ATC

mirtazapine; oral

1.8

307.7

12794

40845

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

307.7

10589

35420

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

307.7

13329

47438

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

307.7

15090

54446

Z3231

NOMESCO Finland

Registered nurse

1.8

307.7

10105

30558

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

307.7

16732

57663

SPAT1263

SPAT

Sampling

1.5

307.7

15767

58401

-1, ,

NOMESCO Finland

1.6

307.7

12725

44646

H02AB06

ATC

prednisolone; systemic

1.7

307.7

18236

64485

XQ802

NOMESCO Finland

Epicutan test

5.9

307.7

1282

1107

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

12.2

307.7

1535

652

DFF15

NOMESCO Finland

Speech audiometry

6.0

307.7

1475

1260

SPAT1216

SPAT

Assessment of functional ability

2.2

307.7

4919

12123

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

9600

30383

XA402

NOMESCO Finland

ENMG

8.4

307.7

751

455

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

307.7

4736

11256

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

18.3

307.7

1902

542

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

307.7

14364

44495

N05CF01

ATC

zopiclone; oral

1.6

307.7

11514

39390

Z00.8

ICD-10 Finland

Other general examinations

3.2

307.7

2743

4448

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

2.9

307.7

5715

10747

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

582.5

307.7

4038

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

41.7

307.7

4486

594

M54.5

ICD-10 Finland

Low back pain

1.7

307.7

13277

45350

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

9.1

307.7

8428

5505

R06.0

ICD-10 Finland

Dyspnoea

1.9

307.7

9479

27403

N03AX16

ATC

[U] pregabalin

2.0

307.7

8122

22089

A04

ICPC

Weakness/tiredness general

2.0

307.7

5152

13868

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.6

307.7

2849

5634

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

55.5

307.7

1124

104

N06AX21

ATC

duloxetine; oral

2.2

307.7

3853

9110

R53

ICD-10 Finland

Malaise and fatigue

1.8

307.7

8892

27378

L03

ICPC

Low back symptom/complaint

1.7

307.7

9658

31365

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

26.3

307.7

2507

503

Z01.8

ICD-10 Finland

Other specified special examinations

11.0

307.7

11012

6349

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

307.7

29508

122870

N03AX12

ATC

[U] gabapentin; oral

2.2

307.7

5514

13428

XCK10

NOMESCO Finland

Photography of fundus of eye

3.0

307.7

3188

5513

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

307.7

21492

84001

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

48.4

307.7

553

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

16196

55888

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

23.0

307.7

523

115

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

37.6

307.7

548

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.0

307.7

5605

14927

Z00.0

ICD-10 Finland

General medical examination

3.6

307.7

8168

12837

N02BE01

ATC

paracetamol; systemic, rectal

2.0

307.7

38391

161904

J01AA02

ATC

doxycycline; systemic

1.5

307.7

31142

132687

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

307.7

2932

6192

Z04.3

ICD-10 Finland

Examination and observation following other accident

59.3

307.7

665

A02BC05

ATC

esomeprazole; systemic

1.7

307.7

14836

51436

N06AX16

ATC

venlafaxine; oral

2.0

307.7

4886

12759

C07AB07

ATC

bisoprolol; oral

1.6

307.7

17228

62391

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

27.6

307.7

1224

228

Z71.8

ICD-10 Finland

Other specified counselling

1.7

307.7

11533

36971

J01DB01

ATC

cefalexin; oral

1.8

307.7

35666

149505

UJF32

NOMESCO Finland

Coloscopy

2.3

307.7

9379

23204

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

88.2

307.7

2845

172

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

4.0

307.7

1791

2328

R42

ICD-10 Finland

Dizziness and giddiness

1.8

307.7

7778

22884

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

307.7

9965

29258

N05AH04

ATC

quetiapine; oral

2.2

307.7

6866

17293

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

120.6

307.7

2484

109

N06AB10

ATC

escitalopram; oral

1.7

306.0

7458

23474

E0000UV, ,

ATC

1.5

305.1

15607

58647

XF402

NOMESCO Finland

ECG with work load test

2.2

304.9

3127

7292

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

304.0

2822

6297

UKC02

NOMESCO Finland

Cystoscopy

1.9

302.3

5243

14889

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

297.7

4139

10887

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

295.4

2640

5787

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

3.8

293.4

1182

1609

SPAT1254

SPAT

Administration of medicine

1.8

290.2

5124

14623

A10AE04

ATC

insulin glargine; parenteral

2.2

289.2

3117

7418

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

286.0

10776

37772

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

284.9

2215

4537

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

284.2

3572

9040

J01CA04

ATC

amoxicillin; systemic

1.5

283.8

34796

154174

P01AB01

ATC

metronidazole; oral, rectal

1.5

283.5

14128

52606

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

280.4

4755

13383

A10AB05

ATC

insulin aspart; parenteral

2.4

279.9

2488

5436

G47.3

ICD-10 Finland

Sleep apnoea

1.6

276.4

7721

25133

XF404

NOMESCO Finland

Ambulatory ECG

2.3

275.3

2664

6049

R01AD09

ATC

mometasone; nasal

1.5

275.1

17008

66015

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

274.7

11015

39096

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

273.0

6394

19841

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

271.8

26894

113799

N03AX09

ATC

lamotrigine; oral

2.9

270.5

1577

2757

XG410

NOMESCO Finland

Flow-volume spirometry

3.6

270.4

1159

1652

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

270.2

4447

12385

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

270.1

1802

3404

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

269.7

6735

21266

A28

ICPC

Limited function/disability NOS

1.8

267.9

5071

14771

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.9

267.0

791

825

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

4.0

265.9

975

1231

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

265.7

20360

82098

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

265.2

2590

5902

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

263.4

14318

54073

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

4.8

262.7

789

834

R06AE07

ATC

cetirizine; oral

1.4

262.3

16456

63884

B01AB05

ATC

enoxaparin; parenteral

1.5

260.2

10342

36562

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

259.9

7681

25321

SFA10

NOMESCO Finland

One-surface restoration

1.4

258.4

21222

86495

J01FF01

ATC

clindamycin; systemic

1.6

258.2

9489

32951

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

258.0

8956

30691

C07AA05

ATC

propranolol; systemic

1.7

257.7

6982

22505

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

256.7

9593

33431

K02.1

ICD-10 Finland

Caries of dentine

1.4

255.4

23409

97207

M03BX02

ATC

tizanidine; oral

1.4

255.2

23729

98779

ZX120

NOMESCO Finland

Intravenous

2.1

255.2

2887

6998

SPAT1310

SPAT

Counselling related to known health issue

1.5

254.0

11129

40149

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.2

253.6

874

1047

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

253.0

6854

22081

J02AC01

ATC

fluconazole; systemic

1.5

252.3

13358

50087

Z01.2

ICD-10 Finland

Dental examination

1.4

252.1

17054

67003

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

251.0

5035

14909

Z01.9

ICD-10 Finland

Special examination, unspecified

2.6

250.4

1757

3409

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

250.1

2637

6207

SPAT1153

SPAT

Removal of sutures

1.5

249.9

10316

36720

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

3.1

248.6

1327

2196

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

248.1

8858

30516

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

247.6

14262

54316

T89

ICPC

Diabetes insulin dependent

3.2

247.6

1257

2014

G44.2

ICD-10 Finland

Tension-type headache

1.8

247.4

4408

12578

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

246.0

8355

28445

R5120

NOMESCO Finland

Preparation of an aid

4.4

244.3

815

949

N02AA05

ATC

oxycodone; systemic

1.7

244.2

5383

16377

SPAT1252

SPAT

Overall medication plan or its review

2.5

244.0

1921

3954

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.0

243.7

1396

2413

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

4.6

242.7

755

825

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

242.7

5777

17959

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.0

242.5

1375

2362

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

242.1

3343

8742

XCH00

NOMESCO Finland

Eye pressure measurement

3.1

241.5

1272

2087

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

47.2

239.1

253

DAX08

NOMESCO Finland

Fitting of hearing aid

2.9

238.7

1406

2471

R05

ICPC

Cough

1.6

238.5

8010

27173

A29

ICPC

General symptom/complaint other

1.9

237.4

3938

10971

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

236.2

7329

24390

R50.9

ICD-10 Finland

Fever, unspecified

1.7

236.2

5138

15563

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

235.6

3030

7715

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

234.8

9453

33397

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

230.3

20805

85571

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

227.8

8181

28151

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

226.9

7620

25816

L01

ICPC

Neck symptom/complaint

1.7

226.7

4979

15111

SFA20

NOMESCO Finland

Two-surface restoration

1.4

226.0

22622

94538

J01DA01

ATC

[U] cefalexin

1.4

226.0

24320

102862

L08

ICPC

Shoulder symptom/complaint

1.6

225.6

6966

23127

R02

ICPC

Shortness of breath/dyspnoea

1.8

225.3

3964

11248

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

224.4

8760

30698

N06AB06

ATC

sertraline; oral

1.9

222.9

3756

10508

T90

ICPC

Diabetes non-insulin dependent

1.6

222.6

7330

24706

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

222.5

3489

9530

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

222.4

5315

16510

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

221.1

4040

11599

WX290

NOMESCO Finland

Other blockage of nerve

1.4

221.0

18251

73755

R11

ICD-10 Finland

Nausea and vomiting

2.0

219.9

2803

7107

ZY010

NOMESCO Finland

Hospital outpatient

2.5

219.8

1663

3353

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

219.5

1352

2438

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

219.5

2840

7242

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

218.4

2983

7760

D07AC01

ATC

betamethasone; topical

1.4

217.1

12797

48677

C10AA01

ATC

simvastatin; oral

1.4

216.5

13372

51301

M79.1

ICD-10 Finland

Myalgia

1.7

216.2

4661

14059

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

215.8

2949

7672

Z01.7

ICD-10 Finland

Laboratory examination

1.7

214.9

4740

14388

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

214.3

19241

78718

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

214.2

1431

2701

R05

ICD-10 Finland

Cough

1.6

212.8

6933

23284

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

212.6

5279

16555

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

212.2

8100

28200

A10AE05

ATC

insulin detemir; parenteral

2.5

212.2

1668

3427

M01AE02

ATC

naproxen; oral, rectal

1.4

210.1

21797

91189

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

209.3

2197

5153

P03

ICPC

Feeling depressed

1.9

208.7

3392

9369

A01

ICPC

Pain general/multiple sites

2.0

208.7

2705

6898

N05AH03

ATC

olanzapine; systemic

2.3

208.4

2033

4620

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

206.6

2087

4815

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

206.0

3268

8953

N06AA09

ATC

amitriptyline; systemic

2.0

205.9

2721

6988

P01

ICPC

Feeling anxious/nervous/tense

1.7

205.5

4278

12762

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

205.3

6742

22665

S29

ICPC

Skin symptom/complaint other

1.6

204.3

6101

20045

SPAT1240

SPAT

Therapeutic discussion

1.8

201.6

3586

10194

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

200.2

4810

14934

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

199.2

5646

18301

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

198.5

2571

6551

S06.0

ICD-10 Finland

Concussion

1.8

198.3

3597

10287

R03DC03

ATC

montelukast; oral

1.6

198.1

5319

17005

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

197.8

5177

16441

B01AC04

ATC

clopidogrel; oral

1.7

197.3

4760

14792

A06AD11

ATC

lactulose; oral

1.7

197.2

4780

14874

M01AH05

ATC

etoricoxib; oral

1.4

196.7

23009

97682

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

196.6

7052

24169

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

196.5

1044

1721

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

196.4

3045

8273

ZXA00

NOMESCO Finland

Right side

1.5

196.0

8534

30493

J01MA12

ATC

levofloxacin; systemic

1.6

195.0

5964

19690

J01EA01

ATC

trimethoprim; systemic

1.5

195.0

8432

30080

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

194.6

11262

42522

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

194.0

4548

14020

R07.3

ICD-10 Finland

Other chest pain

1.9

193.9

3082

8443

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

14.4

193.0

275

P29

ICPC

Psychological sympt/compl other

2.1

191.5

2318

5754

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.5

190.4

1532

3182

SPAT1229

SPAT

Assessment of need for aid

2.1

189.9

2146

5184

N05CF02

ATC

zolpidem; oral

1.6

189.8

5590

18276

A02BC01

ATC

omeprazole; systemic

1.5

189.5

9234

33717

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

189.4

4065

12219

N05BA01

ATC

diazepam; systemic, rectal

1.7

189.2

4119

12431

D01

ICPC

Abdominal pain/cramps general

1.8

188.7

3763

11070

N03AG01

ATC

valproic acid; systemic, rectal

2.2

188.5

1859

4242

P20

ICPC

Memory disturbance

1.8

188.3

3572

10351

A10BA02

ATC

metformin; oral

1.5

187.9

9166

33469

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

187.7

8008

28460

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

187.4

1720

3801

SPAT1097

SPAT

Recording of ECG

1.7

186.9

4236

12929

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

186.6

3849

11435

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

185.7

5343

17362

M01AC06

ATC

meloxicam; systemic, rectal

1.4

185.6

12030

46281

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

185.5

6578

22457

J01FA10

ATC

azithromycin; systemic

1.3

184.6

22188

94207

R01AD08

ATC

fluticasone; nasal

1.4

184.4

9923

36900

ZXA05

NOMESCO Finland

Left side

1.5

184.3

7927

28206

X58

ICD-10 Finland

Exposure to other specified factors

1.6

183.9

4836

15358

C10AA05

ATC

atorvastatin; oral

1.4

182.9

13231

51843

M48.0

ICD-10 Finland

Spinal stenosis

1.8

182.8

3409

9823

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

182.7

3376

9700

A10AB04

ATC

insulin lispro; parenteral

3.2

182.4

924

1477

ZXD05

NOMESCO Finland

Urgent procedure

1.4

181.8

10911

41378

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

181.6

1398

2840

L15

ICPC

Knee symptom/complaint

1.5

180.5

7430

26185

EBA00

NOMESCO Finland

Extraction of tooth

1.4

180.0

13095

51329

J01FA06

ATC

roxithromycin; oral

1.4

179.6

14028

55630

K30

ICD-10 Finland

Functional dyspepsia

1.8

179.3

3364

9709

C08CA01

ATC

amlodipine; oral

1.4

179.3

12200

47275

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.0

178.4

651

818

XKD00

NOMESCO Finland

Uroflowmetry

1.6

178.0

4887

15683

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

175.5

1871

4411

R96

ICPC

Asthma

1.9

175.4

2772

7571

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

175.3

4110

12649

R13

ICD-10 Finland

Dysphagia

2.1

175.1

1919

4576

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

174.6

7987

28739

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

173.7

2741

7481

D11

ICPC

Diarrhoea

1.7

173.2

3925

11966

R52.2

ICD-10 Finland

Other chronic pain

2.9

173.0

1016

1780

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

172.5

3691

11070

N02BF01

ATC

gabapentin; oral

2.0

171.4

2312

5972

A02BA02

ATC

ranitidine; systemic

1.5

171.3

5912

20026

R60.0

ICD-10 Finland

Localized oedema

1.7

171.2

3571

10631

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.2

171.2

596

720

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

171.0

14849

59776

H13

ICPC

Plugged feeling ear

1.6

171.0

5856

19802

H02AB04

ATC

methylprednisolone; systemic

1.6

170.7

4467

14151

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

170.3

6158

21076

A10AB01

ATC

insulin (human); parenteral

2.8

169.9

1074

1964

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

169.3

6514

22598

N03AE01

ATC

clonazepam; systemic

2.2

168.8

1653

3757

N06AB03

ATC

fluoxetine; oral

1.7

168.3

3746

11358

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

168.2

1987

4881

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

168.0

3192

9242

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

167.9

10118

38307

Z50.1

ICD-10 Finland

Other physical therapy

2.4

167.7

1457

3138

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

167.1

13121

51938

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

7.6

167.0

337

224

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.6

166.9

527

584

H03AA01

ATC

levothyroxine sodium; systemic

1.5

166.8

7110

25193

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

166.4

6748

23663

G04CA02

ATC

tamsulosin; oral

1.5

166.3

7839

28341

AN1

Coronary angiography

1.8

166.2

3080

8848

N30.0

ICD-10 Finland

Acute cystitis

1.6

165.9

4946

16181

R55

ICD-10 Finland

Syncope and collapse

1.7

165.6

3425

10168

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

13.1

165.3

245

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

165.0

2121

5381

UJF92

NOMESCO Finland

Capsular endoscopy

4.0

164.2

613

785

N06AX26

ATC

vortioxetine; oral

2.0

164.0

2334

6145

WX002

NOMESCO Finland

Sedation and analgesia

1.5

163.5

5927

20282

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

163.5

2712

7521

Z2445

NOMESCO Finland

Psychologist

2.6

163.3

1207

2401

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

163.1

2366

6270

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

163.1

1948

4805

L13

ICPC

Hip symptom/complaint

1.6

163.0

5068

16742

N17

ICPC

Vertigo/dizziness

1.7

162.7

3505

10525

R74

ICPC

Upper respiratory infection acute

1.4

162.4

11583

45091

WZC30

NOMESCO Finland

Teaching

1.6

162.3

4758

15497

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

162.1

7505

27022

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.6

161.9

691

981

A98

ICPC

Health maint/preventive medicine

1.6

161.8

42640

202693

M01AB05

ATC

diclofenac; systemic, rectal

1.3

161.3

25307

110717

P76

ICPC

Depressive disorder

2.0

161.3

2077

5272

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

160.2

3743

11496

H02

ICPC

Hearing complaint

1.7

159.9

3771

11610

R21

ICPC

Throat symptom/complaint

1.5

159.6

7477

26975

U02

ICPC

Urinary frequency/urgency

1.7

159.4

4017

12588

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

158.6

1771

4252

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

158.6

4999

16561

L12

ICPC

Hand/finger symptom/complaint

1.6

157.8

5142

17167

SFA30

NOMESCO Finland

Three-surface restoration

1.3

157.6

14689

59585

R06AX27

ATC

desloratadine; oral

1.4

157.1

9989

38100

R52.9

ICD-10 Finland

Pain, unspecified

1.8

156.9

2903

8331

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

156.6

2571

7103

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

156.3

2256

5966

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

156.3

2532

6965

N06AX12

ATC

bupropion; oral

1.9

156.3

2277

6042

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

155.7

7618

27699

H04AA01

ATC

glucagon; nasal, parenteral

3.4

154.7

707

1054

A46

ICD-10 Finland

Erysipelas

1.6

154.0

4539

14791

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

153.7

1969

4986

M79.7

ICD-10 Finland

Fibromyalgia

2.9

153.6

880

1519

TAB00

NOMESCO Finland

Lumbar puncture

2.4

153.6

1282

2708

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

153.0

4273

13740

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.0

151.8

854

1458

SPAT1262

SPAT

Handing over of treatment supplies

1.5

151.7

5395

18359

R01AD58

ATC

fluticasone, combinations; nasal

1.4

151.7

8403

31252

A10AE06

ATC

insulin degludec; parenteral

2.7

151.1

1007

1896

R03BA05

ATC

fluticasone; inhalant

1.5

151.0

5998

20901

L16

ICPC

Ankle symptom/complaint

1.7

150.6

3521

10807

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

150.1

6904

24784

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.8

150.1

451

477

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

149.8

3980

12634

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

149.7

2087

5450

A03

ICPC

Fever

1.5

149.6

5880

20442

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

148.9

1605

3797

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.5

148.9

1187

2452

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

148.9

2283

6163

E000001, ,

ATC

1.5

148.7

6755

24187

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.7

148.4

3111

9261

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

148.3

3234

9735

M54.2

ICD-10 Finland

Cervicalgia

1.9

148.3

2340

6378

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

147.9

2077

5438

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.1

147.9

1666

4013

N02BF02

ATC

pregabalin; oral

2.1

147.7

1637

3917

Z3226

NOMESCO Finland

Physiotherapist

1.5

147.5

5755

19970

A10AC01

ATC

insulin (human); parenteral

1.9

146.9

2320

6324

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

146.8

12160

48327

CS494

NOMESCO Finland

Other visual field testing

3.6

145.5

618

874

N05BA12

ATC

alprazolam; oral

1.7

145.0

2960

8741

M01AX17

ATC

nimesulide; oral

1.4

144.6

7287

26603

C01CA24

ATC

epinephrine; parenteral

2.0

144.0

1830

4619

SPAT1360

SPAT

Extensive global examination

2.0

143.9

2003

5227

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

143.7

7710

28472

A02BC04

ATC

rabeprazole; oral

1.8

143.5

2543

7195

XG405

NOMESCO Finland

Education on PEF monitoring

5.4

143.2

383

360

B01AA03

ATC

warfarin; systemic

1.5

143.1

5948

20904

R35

ICD-10 Finland

Polyuria

2.0

142.8

1894

4857

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

142.3

1149

2388

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

142.2

3180

9635

N05AX12

ATC

aripiprazole; systemic

2.4

141.7

1238

2671

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.1

141.6

1561

3727

D07AC13

ATC

mometasone; topical

1.4

141.0

9837

37998

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

141.0

8726

33037

J05AB01

ATC

aciclovir; systemic

1.4

140.8

6960

25303

N06BA04

ATC

methylphenidate; oral

2.5

140.2

1057

2123

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

140.1

5525

19199

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

139.2

9812

37954

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

138.7

38292

179305

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

138.4

12518

50325

SPAT1260

SPAT

Consultation of another employee

1.5

138.2

5549

19350

N01

ICPC

Headache

1.6

137.6

3637

11518

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

137.5

7170

26314

UDC00

NOMESCO Finland

Ear microscopy

1.9

137.2

2192

5996

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

137.0

2338

6533

A11

ICPC

Chest pain NOS

1.9

136.9

2251

6216

SPAT1234

SPAT

Support of social functional capacity

2.2

136.5

1427

3332

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

136.2

3150

9629

R31

ICD-10 Finland

Unspecified haematuria

1.7

136.0

3095

9419

R01AD12

ATC

fluticasone furoate; nasal

1.3

135.6

11023

43578

Z2446

NOMESCO Finland

Social worker

1.9

135.4

1991

5295

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

135.2

888

1658

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

134.3

3377

10554

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

134.2

4009

13081

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

134.1

27353

122420

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

134.0

1877

4907

C10AA07

ATC

rosuvastatin; oral

1.4

133.8

9670

37516

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

133.6

2466

7061

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.2

133.2

666

1055

R03BB04

ATC

tiotropium bromide; inhalant

1.7

133.1

2927

8822

H25.8

ICD-10 Finland

Other senile cataract

1.7

132.9

2879

8641

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

132.7

2784

8280

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

132.6

3764

12129

A10BH01

ATC

sitagliptin; oral

1.8

132.5

2584

7522

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

132.4

2097

5718

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

132.0

1233

2742

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.2

131.9

660

1046

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.8

131.3

812

1466

R03BA08

ATC

ciclesonide; inhalant

1.8

131.0

2469

7114

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

130.9

3313

10370

M01AH01

ATC

celecoxib; oral

1.5

130.8

5307

18531

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

130.6

1769

4569

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

130.2

2555

7451

R00.2

ICD-10 Finland

Palpitations

1.8

130.1

2212

6172

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

129.7

1203

2667

R03BA02

ATC

budesonide; inhalant

1.5

129.0

5741

20418

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

128.2

3030

9312

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

128.0

9468

36827

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

18.0

128.0

168

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.6

127.7

915

1790

P06

ICPC

Sleep disturbance

1.6

127.7

3705

11999

T78.4

ICD-10 Finland

Allergy, unspecified

2.2

127.6

1295

2986

J01MA14

ATC

moxifloxacin; systemic

1.7

127.4

2597

7658

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

127.3

6168

22295

H01

ICPC

Ear pain/earache

1.6

127.0

3603

11603

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

126.9

1553

3861

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.2

126.8

1240

2814

H29

ICPC

Ear symptom/complaint other

1.6

126.1

3270

10295

C09AA05

ATC

ramipril; oral

1.4

126.1

7654

28811

L29

ICPC

Musculoskeletal sympt/complt other

1.8

126.0

2424

7026

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

126.0

3331

10540

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

125.7

765

1368

UJD02

NOMESCO Finland

Gastroscopy

2.2

125.5

1305

3040

G04BD12

ATC

mirabegron; oral

1.7

125.4

3026

9349

SPAT1312

SPAT

General health counselling

1.3

125.4

11034

44049

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

125.3

6749

24871

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

125.3

2700

8087

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

125.0

4381

14818

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

125.0

2676

8001

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

124.9

2070

5727

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

124.8

3360

10680

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.7

124.2

815

1521

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.5

124.1

551

805

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

123.8

7580

28563

H3600, E103,

ICD-10 Finland

5.6

123.6

317

285

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

123.2

4105

13726

J01FA09

ATC

clarithromycin; systemic

1.3

122.9

10624

42278

R5599

NOMESCO Finland

Other rehabilitation service

2.8

122.3

739

1316

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

122.2

2790

8491

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

122.0

2894

8899

R29

ICPC

Respiratory symptom/complaint other

1.9

121.9

1911

5191

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

121.9

2140

6030

C10AX09

ATC

ezetimibe; oral

1.5

121.5

4344

14750

N05AX08

ATC

risperidone; systemic

1.7

121.4

2595

7754

R06AX22

ATC

ebastine; oral

1.5

121.0

5402

19206

ZXA10

NOMESCO Finland

Bilateral

1.5

120.7

5593

20029

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

120.6

1321

3144

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.3

120.3

1074

2340

SDA03

NOMESCO Finland

Periodontal treatment

1.3

119.9

14077

58428

R06.5

ICD-10 Finland

Mouth breathing

1.7

119.8

2736

8326

P99

ICPC

Psychological disorders other

2.6

119.7

867

1706

SFA00

NOMESCO Finland

Small restoration

1.5

119.3

4268

14491

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

119.2

6737

25020

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.3

119.1

401

471

A10AA01, ,

ATC

2.8

118.3

723

1296

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

118.2

730

1317

F34.1

ICD-10 Finland

Dysthymia

2.4

118.2

1007

2147

D19

ICPC

Teeth/gum symptom/complaint

1.3

117.7

9556

37632

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.1

117.6

1358

3300

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

117.6

1299

3102

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

117.3

4267

14538

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

117.3

2686

8178

E66.8

ICD-10 Finland

Other obesity

2.0

117.0

1584

4088

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

116.8

5914

21525

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

116.5

1998

5586

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

116.5

13971

58093

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

116.3

9405

37004

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

116.3

1183

2730

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

116.2

3301

10625

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

116.1

6774

25284

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

116.1

1730

4618

SPAT1359

SPAT

Use of symptom diary

3.1

115.6

597

966

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

115.3

2213

6405

SPAT1043

SPAT

Audiometry

1.7

115.3

2681

8195

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

115.2

1480

3747

A05

ICPC

Feeling ill

1.8

115.0

1952

5440

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

114.6

3469

11335

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

113.6

1713

4591

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

113.5

18826

81437

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

113.2

4153

14168

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.2

112.9

570

909

TQW80

NOMESCO Finland

Local dermatologic skincare

2.8

112.9

697

1257

C01DA14

ATC

isosorbide mononitrate; oral

1.5

112.7

4638

16208

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

112.6

2136

6160

SPAT1104

SPAT

Monitoring of emergency patient

1.9

112.6

1827

5017

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

8.8

112.4

205

117

J01CA08

ATC

pivmecillinam; oral

1.3

112.0

12767

52671

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

112.0

2630

8060

J45.8

ICD-10 Finland

Mixed asthma

2.5

111.9

831

1656

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

4.5

111.3

352

391

SPAT1255

SPAT

Intravenous administration of medicine

1.8

111.0

1904

5322

R06AE09

ATC

levocetirizine; oral

1.5

111.0

4562

15934

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

111.0

1874

5213

M02AA07

ATC

piroxicam; topical

1.3

110.7

11619

47394

L20.0

ICD-10 Finland

Besnier prurigo

1.7

110.2

2276

6729

K07.60

ICD-10 Finland

Snapping jaw

2.0

109.7

1440

3674

D07AD01

ATC

clobetasol; topical

1.5

109.6

4942

17580

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

109.5

1707

4626

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

109.3

4217

14535

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

109.3

2733

8513

D02

ICPC

Abdominal pain epigastric

1.9

109.2

1654

4438

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

109.1

3834

12955

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

108.9

3500

11592

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

108.8

1942

5497

RF410, ,

NOMESCO Finland

5.3

108.7

294

280

127

Kela drug reimbursment

Transplant complication

3.9

108.6

410

530

L02

ICPC

Back symptom/complaint

1.6

107.9

3014

9654

C08CA13

ATC

lercanidipine; oral

1.5

107.8

3893

13230

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

107.0

8912

35156

R83

ICPC

Respiratory infection other

1.3

106.9

9069

35872

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

182.9

106.8

146

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

106.8

1372

3472

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

106.4

742

1431

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

106.4

592

1004

N04BC05

ATC

pramipexole; oral

1.8

106.0

1974

5660

D06

ICPC

Abdominal pain localized other

1.7

105.8

2458

7507

S97

ICPC

Chronic ulcer skin

1.9

105.6

1557

4139

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

105.6

1709

4688

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

105.3

1221

2972

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

104.8

12257

50639

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

104.7

8895

35173

L14

ICPC

Leg/thigh symptom/complaint

1.7

104.6

2179

6457

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.4

104.4

863

1813

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

104.3

1026

2333

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

104.3

1009

2278

P74

ICPC

Anxiety disorder/anxiety state

2.0

103.8

1273

3166

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.2

103.6

518

821

R4110

NOMESCO Finland

Physiotherapy

1.3

103.5

8840

34975

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

103.3

1445

3772

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

103.1

2296

6931

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

102.8

11883

48997

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.5

102.7

774

1554

R33

ICD-10 Finland

Retention of urine

1.7

102.5

2310

6995

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

102.4

3943

13576

M04AA01

ATC

allopurinol; systemic

1.5

102.2

3860

13235

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

102.2

1082

2538

R01AD01

ATC

beclometasone; nasal

1.4

102.1

4714

16830

R01AD11

ATC

triamcinolone; nasal

1.7

101.9

2483

7679

M02AA10

ATC

ketoprofen; topical

1.4

101.9

4741

16951

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

101.9

2088

6157

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

101.3

1127

2698

R03BA01

ATC

beclometasone; inhalant

1.5

101.2

4185

14619

R5110, ,

SPAT

1.9

101.1

1599

4352

S21

ICPC

Skin texture symptom/complaint

1.5

101.1

4159

14513

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

101.0

2036

5975

R03AC03

ATC

terbutaline; inhalant

1.5

100.8

4261

14949

L04AX01

ATC

azathioprine; systemic

2.1

100.3

1186

2908

L11

ICPC

Wrist symptom/complaint

1.6

100.2

2570

8054

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.2

100.1

1035

2404

SPAT1053

SPAT

Memory test

1.5

99.8

3550

12015

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

99.7

1174

2874

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

99.6

2126

6341

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

98.9

1440

3811

M01AX05

ATC

glucosamine; oral

1.4

98.6

5045

18350

R1250

NOMESCO Finland

Evaluation of functional capability

2.8

98.1

590

1048

C05AA08

ATC

fluocortolone; rectal, topical

1.5

98.1

4021

14017

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.1

98.1

505

816

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

98.0

2035

6022

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

98.0

849

1824

K03.66

ICD-10 Finland

Tooth plaque

1.7

97.8

2126

6373

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

97.8

3296

11023

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

97.7

1706

4793

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.3

97.7

927

2075

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

97.6

2037

6037

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

97.5

1936

5656

M01AH02

ATC

rofecoxib; oral

1.5

97.4

3504

11886

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.9

97.2

365

470

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

97.0

1313

3386

C09CA06

ATC

candesartan; oral

1.3

96.8

7266

28164

R4110, ,

SPAT

1.7

96.7

2191

6642

C03DA01

ATC

spironolactone; oral

1.5

96.7

3369

11348

S22.3

ICD-10 Finland

Fracture of rib

1.7

96.5

2066

6166

J01DA09

ATC

[U] cefadroxil

1.3

95.9

9000

36029

Z2221

NOMESCO Finland

Medical doctor

1.3

95.8

9051

36265

G04CA01

ATC

alfuzosin; oral

1.5

95.8

3740

12906

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

95.8

719

1441

L04AA06

ATC

mycophenolic acid; systemic

3.2

95.7

484

773

J05AB11

ATC

valaciclovir; oral

1.5

95.7

4240

15007

H02AB09

ATC

hydrocortisone; systemic

2.8

95.6

610

1121

SPAT1325

SPAT

Vaccination

1.3

95.5

10719

43947

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.7

95.5

1886

5500

N76.0

ICD-10 Finland

Acute vaginitis

1.8

95.4

1742

4962

N39.3

ICD-10 Finland

Stress incontinence

1.8

95.4

1658

4651

C09CA01

ATC

losartan; oral

1.3

95.0

7584

29658

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

95.0

1495

4062

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

94.9

776

1622

A99

ICPC

Disease/condition unspecnature/site

1.6

94.5

2610

8328

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

94.3

1165

2905

A07AA02

ATC

nystatin; oral

1.9

94.3

1469

3978

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

94.1

13525

57150

207

Kela drug reimbursment

Chronic arrhythmias

1.5

94.1

4186

14825

SPAT1211

SPAT

Application of soft bandage

1.6

93.9

2497

7894

K78

ICPC

Atrial fibrillation/flutter

1.7

93.8

1938

5725

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.0

93.8

1232

3143

H93.1

ICD-10 Finland

Tinnitus

1.7

93.8

1868

5461

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

93.3

2093

6327

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.2

93.3

997

2348

H36.01

ICD-10 Finland

Diabetic maculopathy

4.0

93.3

338

423

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.5

93.1

730

1495

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.7

93.1

608

1132

W19

ICD-10 Finland

Unspecified fall

1.6

93.0

2952

9736

-50

ICPC

Medication/prescr/renewal

2.1

92.8

1064

2578

XG466

NOMESCO Finland

Sleep oxymetry

2.4

92.6

799

1713

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

92.5

1333

3515

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.8

92.4

563

1008

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.3

92.3

835

1830

Z04.1

ICD-10 Finland

Examination and observation following transport accident

15.3

92.2

128

C07AB02

ATC

metoprolol; systemic

1.4

91.9

6009

22772

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

91.6

10994

45415

R09

ICPC

Sinus symptom/complaint

1.6

91.4

2349

7360

HMAK, ,

NOMESCO Finland

1.5

91.3

3565

12296

F29

ICPC

Eye symptom/complaint other

1.6

91.3

2685

8698

H40.0

ICD-10 Finland

Glaucoma suspect

1.7

91.2

2040

6162

Z12.5

ICD-10 Finland

Special screening examination for neoplasm of prostate

5.8

91.0

227

198

H02AB07

ATC

prednisone; oral

1.5

90.8

4013

14187

H91.1

ICD-10 Finland

Presbycusis

1.8

90.7

1603

4519

-, ,

ICD-10 Finland

2.7

90.7

591

1099

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.4

90.6

409

605

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

22.3

90.4

111

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

90.2

1844

5430

Z11

ICPC

Compliance/being ill problem

6.3

90.0

208

166

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.3

89.9

305

361

G04CB01

ATC

finasteride; oral

1.5

89.8

3268

11105

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

89.5

4910

18060

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

89.5

3121

10507

Z03.0

ICD-10 Finland

Observation for suspected tuberculosis

27.5

89.3

104

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

89.3

1034

2515

J34.2

ICD-10 Finland

Deviated nasal septum

1.8

89.2

1565

4402

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

89.2

1458

4010

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

89.1

1525

4256

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.0

89.1

488

820

L04AX03

ATC

methotrexate; systemic

1.6

89.1

2728

8919

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

88.9

1914

5720

RF420, ,

NOMESCO Finland

4.0

88.7

324

408

L04

ICPC

Chest symptom/complaint

1.8

88.6

1670

4801

-34

ICPC

Blood test

2.4

88.4

762

1633

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

2.9

88.3

507

877

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

88.1

914

2126

H26.4

ICD-10 Finland

After-cataract

1.6

88.0

2450

7830

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

87.8

2945

9830

XA420

NOMESCO Finland

Extensive sleep examination

4.9

87.6

257

266

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.8

87.5

539

971

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

87.5

1261

3325

WX704

NOMESCO Finland

Intubation

1.6

87.4

2270

7129

K22

ICPC

Risk factor cardiovascular disease

1.9

87.4

1383

3763

N06AX22

ATC

agomelatine; oral

2.6

87.4

615

1192

N07CA01

ATC

betahistine; oral

1.7

87.3

1899

5690

B01AF02

ATC

apixaban; oral

1.5

87.2

3235

11034

ACC51

NOMESCO Finland

Release of median nerve

1.7

87.2

1981

6008

SGA01

NOMESCO Finland

Emergency treatment

1.4

86.8

5398

20275

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

86.7

3190

10862

R12

ICD-10 Finland

Heartburn

1.6

86.5

2258

7100

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

86.5

2204

6888

SPAT1058

SPAT

PEF monitoring instruction

1.6

86.5

2132

6607

XQ801

NOMESCO Finland

Intracutantest

16.0

86.5

118

N03AF02

ATC

oxcarbazepine; oral

2.2

86.2

906

2119

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

86.1

7738

30729

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

86.1

1542

4365

B01AF01

ATC

rivaroxaban; oral

1.5

86.1

3257

11155

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

86.0

1658

4799

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.4

86.0

706

1479

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

85.9

1431

3959

K29

ICPC

Cardiovascular sympt/complt other

2.1

85.7

1030

2541

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

85.7

3672

12898

H53.2

ICD-10 Finland

Diplopia

2.3

85.5

808

1806

M05BA04

ATC

alendronic acid; oral

1.7

85.5

2073

6397

SPAT1059

SPAT

Spirometry at the office

1.9

85.3

1307

3518

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

85.3

7661

30414

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

85.3

844

1924

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

85.2

1723

5057

J30.3

ICD-10 Finland

Other allergic rhinitis

2.1

85.2

983

2387

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.0

85.2

1050

2616

Z29

ICPC

Social problem NOS

2.6

85.0

585

1121

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

84.8

7396

29241

U01

ICPC

Dysuria/painful urination

1.7

84.2

2048

6324

U07

ICPC

Urine symptom/complaint other

1.7

84.1

1926

5852

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.6

84.1

2442

7882

S04

ICPC

Lump/swelling localized

1.5

84.0

2983

10077

K07

ICPC

Swollen ankles/oedema

2.0

83.9

1076

2720

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

83.9

6308

24400

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

83.9

2599

8518

A10BK03

ATC

empagliflozin; oral

1.6

83.8

2498

8112

U04

ICPC

Incontinence urine

1.9

83.7

1262

3379

Z13.6

ICD-10 Finland

Special screening examination for cardiovascular disorders

7.8

83.4

165

107

F41.00

ICD-10 Finland

Moderate panic disorder

3.1

83.4

436

712

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

83.3

2029

6267

G04BD08

ATC

solifenacin; oral

1.8

83.2

1584

4567

-42

ICPC

Electrical tracing

3.7

82.9

332

450

-69

ICPC

Other reason for encounter NEC

2.1

82.8

984

2417

U05

ICPC

Urination problems other

1.9

82.8

1268

3413

S80.0

ICD-10 Finland

Contusion of knee

1.6

82.6

2148

6747

K04

ICPC

Palpitations/awareness of heart

1.8

82.4

1355

3734

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

82.3

3757

13352

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

82.3

3591

12652

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

82.2

1638

4787

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.9

82.0

240

248

H3601, E103,

ICD-10 Finland

4.9

82.0

239

246

H57.1

ICD-10 Finland

Ocular pain

2.1

81.9

986

2434

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

81.9

2867

9654

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

81.7

928

2240

F61.0

ICD-10 Finland

Mixed personality disorders

3.0

81.1

437

727

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

5.9

81.0

197

167

N03AX11

ATC

topiramate; oral

2.5

81.0

624

1267

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

80.9

2361

7628

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

80.4

1518

4366

A08

ICPC

Swelling

1.9

80.2

1229

3308

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

5.0

80.2

227

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

80.0

1447

4107

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.4

80.0

653

1364

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

80.0

1626

4778

N06AX03

ATC

mianserin; oral

1.9

80.0

1214

3257

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

79.9

1222

3287

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

79.9

3897

14019

SPAT1283

SPAT

Restricted health certificate

1.3

79.8

5976

23085

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.0

79.5

434

728

N06AB05

ATC

paroxetine; oral

1.7

79.5

1603

4700

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

79.3

1350

3760

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.8

79.2

1479

4240

N07BB01

ATC

disulfiram; oral

1.9

79.2

1244

3377

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

79.0

2238

7178

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

78.9

783

1787

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.7

78.9

320

438

Y96.9

ICD-10 Finland

Unspecified type of accident

2.9

78.8

469

829

K92.1

ICD-10 Finland

Melaena

1.8

78.6

1441

4107

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.6

78.4

2418

7912

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.5

77.9

589

1185

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.6

77.9

538

1033

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

77.8

2573

8553

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.8

77.8

488

889

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

7.9

77.7

152

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.8

77.6

298

391

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.8

77.5

1378

3891

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

77.4

1453

4171

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

77.4

1355

3808

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.7

77.1

1648

4912

N05AN01

ATC

lithium; oral

2.4

77.1

629

1314

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.2

77.0

212

206

D07XC01

ATC

betamethasone; topical

1.4

76.9

3590

12805

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

76.8

850

2030

S76

ICPC

Skin infection other

1.8

76.8

1403

3995

K04.08

ICD-10 Finland

Other specified pulpit

1.6

76.7

2312

7524

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

8.1

76.7

147

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

76.6

8387

34124

S01ED51

ATC

timolol, combinations; ophthalmic

1.6

76.4

1951

6098

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

76.3

914

2252

L04AD02

ATC

tacrolimus; systemic

4.1

76.3

271

334

WX320

NOMESCO Finland

Spinalanesthesy

1.3

76.2

7260

29002

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

76.2

793

1847

M54.3

ICD-10 Finland

Sciatica

1.7

76.0

1577

4661

K59.0

ICD-10 Finland

Constipation

1.7

76.0

1506

4393

R06AX13

ATC

loratadine; oral

1.4

76.0

4647

17380

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

75.8

989

2516

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

75.7

1928

6021

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

75.7

3066

10637

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

75.5

2687

9075

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

75.5

913

2258

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

75.5

976

2475

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

75.3

10172

42441

WX892

NOMESCO Finland

Monitored bed care

1.6

75.2

2047

6501

L86

ICPC

Back syndrome with radiating pain

1.7

75.1

1550

4574

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

75.1

4810

18123

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.9

75.1

1040

2704

A06AC51

ATC

ispaghula, combinations; oral

1.9

75.1

1194

3254

D07AB08

ATC

desonide; topical

1.5

74.5

3266

11508

N06AX05

ATC

trazodone; oral

2.4

74.5

624

1320

K08.80

ICD-10 Finland

Toothache NOS

1.5

74.5

2503

8349

N05BE01

ATC

buspirone; oral

2.2

74.4

749

1720

K80

ICPC

Cardiac arrhythmia NOS

1.6

74.4

2035

6471

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

74.3

2699

9156

N81.6

ICD-10 Finland

Rectocele

1.8

74.2

1330

3764

UJH02

NOMESCO Finland

Anoscopy

1.9

74.2

1028

2673

RD210, ,

NOMESCO Finland

2.8

74.1

453

813

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

74.0

5684

22020

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

73.9

1577

4697

H3603, E103,

ICD-10 Finland

4.2

73.9

253

302

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

2.0

73.9

1021

2652

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.0

73.9

211

213

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

73.8

1480

4331

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.6

73.8

529

1036

L05

ICPC

Flank/axilla symptom/complaint

1.7

73.8

1582

4719

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

73.7

1390

3995

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

73.6

545

1085

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

73.4

2534

8501

EB1VA, ,

NOMESCO Finland

1.4

73.1

3640

13135

WX872

NOMESCO Finland

Intensive care

1.8

73.0

1316

3731

114

Kela drug reimbursment

Glaucoma

1.6

72.9

2222

7249

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

72.8

1437

4187

A10BH05

ATC

linagliptin; oral

1.8

72.7

1224

3397

R07.0

ICD-10 Finland

Pain in throat

1.6

72.6

2051

6571

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

72.4

1203

3325

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.0

72.2

883

2193

N05CD07

ATC

temazepam; oral

1.4

72.2

3340

11889

SPAT1285

SPAT

Provision of consultation response

1.8

72.0

1377

3975

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

71.9

11648

49554

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.3

71.9

347

538

WX722

NOMESCO Finland

PEEP

1.8

71.8

1169

3210

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.7

71.7

483

915

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.1

71.7

170

140

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

71.7

2235

7328

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

71.7

1356

3901

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.8

71.6

1333

3817

S01

ICPC

Pain/tenderness of skin

1.8

71.5

1211

3367

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

71.5

1731

5335

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

26.4

71.4

R04.2

ICD-10 Finland

Haemoptysis

2.0

71.3

878

2187

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

71.1

2001

6405

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

71.1

915

2317

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.6

70.9

482

918

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

70.8

1614

4895

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

70.7

970

2513

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.5

70.6

223

248

K90

ICPC

Stroke/cerebrovascular accident

2.3

70.6

663

1478

GX1K5

NOMESCO Finland

Diffusion capacity

9.9

70.6

120

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

70.5

641

1408

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

3.3

70.4

334

512

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

70.4

1357

3926

M10.9

ICD-10 Finland

Gout, unspecified

1.6

70.3

1805

5648

D12

ICPC

Constipation

2.0

70.2

867

2162

U29

ICPC

Urinary symptom/complaint other

2.2

70.1

720

1668

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

70.1

1079

2909

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

70.0

6598

26291

Z08

ICPC

Social welfare problem

3.3

69.9

328

499

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

69.9

2739

9435

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

69.9

2050

6627

M54.1

ICD-10 Finland

Radiculopathy

1.9

69.8

1018

2694

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

4.3

69.5

231

269

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

69.4

1492

4453

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

69.3

3431

12361

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

69.0

2677

9201

Z94.0

ICD-10 Finland

Kidney transplant status

3.7

69.0

273

367

R04

ICPC

Breathing problem other

2.0

68.9

937

2420

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.2

68.9

346

551

S15

ICPC

Foreign body in skin

1.7

68.8

1617

4944

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

68.8

1539

4644

LGA22

NOMESCO Finland

Hysteroscopic sterilisation

4.6

68.7

213

233

B02AA02

ATC

tranexamic acid; systemic

1.4

68.5

4069

15128

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.7

68.2

434

797

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

68.1

1646

5071

P01BA02

ATC

hydroxychloroquine; oral

1.6

67.9

2105

6891

P15

ICPC

Chronic alcohol abuse

2.1

67.8

803

1970

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

67.8

4104

15306

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

63.4

67.8

101

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.9

67.6

1037

2792

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

67.4

2600

8926

L50.8

ICD-10 Finland

Other urticaria

2.7

67.3

434

803

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

67.3

538

1113

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.5

67.1

507

1020

R04.0

ICD-10 Finland

Epistaxis

1.6

67.1

1982

6417

S10

ICPC

Boil/carbuncle

1.7

67.0

1556

4742

F32.8

ICD-10 Finland

Other depressive episodes

2.8

66.8

423

775

R51

ICD-10 Finland

Headache

1.7

66.8

1566

4786

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

66.7

2145

7081

L76

ICPC

Fracture: other

2.2

66.7

688

1597

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

66.5

1144

3197

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

66.4

1967

6372

SAA04

NOMESCO Finland

Special examination of mouth

1.7

66.4

1483

4473

A10AA02, ,

ATC

2.0

66.4

877

2242

J45

ICD-10 Finland

Asthma

1.5

66.3

2895

10187

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.4

66.2

564

1203

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

66.1

1852

5920

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.6

66.1

472

923

-60

ICPC

Result test/procedure

1.7

66.0

1467

4418

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

66.0

689

1607

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.9

65.9

1008

2711

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.4

65.9

559

1190

N05AA02

ATC

levomepromazine; systemic

1.8

65.7

1067

2927

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.0

65.7

857

2181

C10AC01

ATC

colestyramine; oral

2.2

65.6

629

1415

XCW10

NOMESCO Finland

Assessment of vision

3.5

65.6

281

401

S01EE01

ATC

latanoprost; ophthalmic

1.7

65.6

1519

4626

A10BK01

ATC

dapagliflozin; oral

1.6

65.5

1776

5633

N06AA12

ATC

doxepin; systemic

1.8

65.4

1258

3636

K05.30

ICD-10 Finland

Periodontitis complex

1.4

65.4

3994

14913

XQ820

NOMESCO Finland

Exposure to medicinal substance

13.6

65.4

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

65.3

606

1344

SPAT1167

SPAT

Insertion of urinary catheter

2.1

65.2

760

1853

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

65.2

2245

7523

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

65.0

4348

16472

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.0

65.0

870

2235

U71

ICPC

Cystitis/urinary infection other

1.6

64.9

1607

4980

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

64.8

1214

3482

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

64.8

1645

5132

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

64.7

811

2033

R15

ICD-10 Finland

Faecal incontinence

2.3

64.7

569

1232

XQ848

NOMESCO Finland

Dermatological photography

2.1

64.5

717

1716

R51.81

ICD-10 Finland

Facial pain NOS

2.4

64.5

551

1177

H92.0

ICD-10 Finland

Otalgia

1.6

64.5

1655

5177

J46

ICD-10 Finland

Status asthmaticus

2.2

64.4

668

1554

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

64.4

1144

3229

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

64.3

1049

2883

L84

ICD-10 Finland

Corns and callosities

2.0

64.2

853

2185

E000006, ,

ATC

1.6

64.2

1792

5723

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.4

64.1

532

1121

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

64.0

1420

4274

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

64.0

878

2275

R4190

NOMESCO Finland

Nutritional therapy

1.9

63.9

985

2657

D07AA02

ATC

hydrocortisone; topical

1.3

63.9

4445

16940

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.0

63.7

354

601

N03AF01

ATC

carbamazepine; oral, rectal

1.7

63.7

1299

3820

TK800

NOMESCO Finland

Hemodialysis

2.4

63.6

521

1091

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

63.6

728

1763

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

63.3

1859

6008

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

2.3

63.2

586

1299

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

63.2

3284

11927

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

63.1

1146

3256

M35.7

ICD-10 Finland

Hypermobility syndrome

3.0

62.9

341

570

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

4.4

62.9

207

239

L09

ICPC

Arm symptom/complaint

1.7

62.9

1246

3633

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

62.8

791

1987

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

62.6

1672

5281

RF120, ,

NOMESCO Finland

3.6

62.6

265

375

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

62.6

1654

5211

G04CB02

ATC

dutasteride; oral

1.5

62.6

2001

6596

R06.2

ICD-10 Finland

Wheezing

1.8

62.5

1154

3295

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

62.5

1512

4658

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.4

62.5

284

423

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

62.5

6728

27233

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

62.4

1683

5330

F43.00

ICD-10 Finland

Acute stress reaction mild

2.2

62.4

638

1476

G54.0

ICD-10 Finland

Brachial plexus disorders

2.2

62.2

653

1527

D09

ICPC

Nausea

1.7

62.1

1277

3763

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.0

62.1

334

556

D02AE01

ATC

carbamide; topical

1.6

61.9

1700

5407

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

61.9

1782

5733

A01AB09

ATC

miconazole; local oral

1.5

61.6

2300

7839

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.8

61.6

1137

3247

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

61.6

2137

7172

I50.0

ICD-10 Finland

Congestive heart failure

1.5

61.3

2024

6720

R30.0

ICD-10 Finland

Dysuria

1.8

61.2

1094

3094

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.1

61.0

656

1550

A10BJ06

ATC

semaglutide; parenteral

1.7

60.9

1220

3568

PLAK1, ,

NOMESCO Finland

3.5

60.9

268

390

A02BA04

ATC

nizatidine; systemic

1.5

60.9

1978

6543

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.6

60.8

187

203

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

60.8

1344

4042

P25

ICPC

Phase of life problem adult

1.8

60.8

1137

3260

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

60.8

2941

10544

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

60.8

2572

8991

A11CC03

ATC

alfacalcidol; systemic

2.3

60.7

566

1258

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.8

60.7

1134

3250

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

60.7

1990

6596

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.1

60.6

309

497

R07

ICPC

Sneezing/nasal congestion

1.5

60.6

1926

6340

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

60.5

1906

6262

R52.0

ICD-10 Finland

Acute pain

1.9

60.2

864

2275

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.4

60.1

493

1033

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.4

60.1

272

404

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

60.1

1531

4780

CKC12

NOMESCO Finland

Photocoagulation of retina

1.8

59.9

1041

2918

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.4

59.9

2640

9301

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

59.8

848

2223

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

59.8

929

2512

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.1

59.7

668

1603

VALMI, ,

NOMESCO Finland

1.2

59.7

8216

34215

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

59.6

2191

7442

M54.8

ICD-10 Finland

Other dorsalgia

1.8

59.6

1131

3256

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

59.6

1540

4824

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.8

59.5

1086

3090

L84

ICPC

Back syndrome without radiat pain

1.7

59.5

1188

3472

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

59.5

784

2003

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.4

59.4

499

1058

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

59.4

651

1550

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

59.3

540

1188

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

59.2

2638

9312

JAH01

NOMESCO Finland

Laparoscopy

1.8

59.2

1062

3007

M01AB55

ATC

diclofenac, combinations; oral

1.6

59.0

1642

5238

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.0

59.0

728

1815

B02.9

ICD-10 Finland

Zoster without complication

1.6

58.9

1585

5015

J02AC02

ATC

itraconazole; systemic

1.3

58.9

5080

19959

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

58.8

3081

11201

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.3

58.8

273

413

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

58.7

503

1076

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

58.5

2304

7939

SPAT1251

SPAT

Organisation of medication

1.9

58.5

919

2495

A03FA02

ATC

cisapride; oral, rectal

1.5

58.4

1935

6428

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

58.4

537

1187

F03

ICPC

Eye discharge

1.6

58.3

1765

5745

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

58.2

1757

5715

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

58.0

1774

5787

S01BC05

ATC

ketorolac; ophthalmic

1.8

58.0

981

2727

R52.1

ICD-10 Finland

Chronic intractable pain

3.9

58.0

218

282

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

57.9

2732

9747

SPAT1101

SPAT

Orthostatic test

1.8

57.9

984

2740

L57.0

ICD-10 Finland

Actinic keratosis

1.5

57.7

2521

8863

N27

ICPC

Fear of neurological disease other

2.9

57.7

341

601

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.3

57.7

191

222

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

57.6

6024

24267

C10AA04

ATC

fluvastatin; oral

1.5

57.6

2071

7001

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

57.6

1177

3463

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.7

57.5

1224

3642

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.8

57.4

970

2695

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

57.3

2973

10789

SPAT1172

SPAT

Guidance concerning hydration

2.3

57.2

515

1127

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

57.2

1709

5546

J01AA04

ATC

lymecycline; systemic

1.3

57.1

4110

15728

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

5.8

57.1

142

124

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.9

57.0

216

281

G04BD07

ATC

tolterodine; oral

1.7

57.0

1174

3462

T74.1

ICD-10 Finland

Physical abuse

2.3

56.9

498

1076

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.0

56.9

718

1805

H16.0

ICD-10 Finland

Corneal ulcer

1.7

56.7

1348

4133

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.8

56.7

356

650

CL2S4, ,

SPAT

3.0

56.6

313

530

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

56.5

2838

10238

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.9

56.5

777

2016

J01CF05

ATC

flucloxacillin; systemic

1.6

56.4

1686

5472

E000002, ,

ATC

1.4

56.3

3326

12336

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.9

56.3

896

2442

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

56.1

1037

2962

A23

ICPC

Risk factor NOS

1.4

56.1

2556

9057

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

56.1

1696

5518

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.9

56.0

210

271

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

56.0

2618

9322

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.4

56.0

2914

10579

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

56.0

1077

3114

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

55.9

2341

8162

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

55.9

3502

13113

B82

ICPC

Anaemia other/unspecified

2.1

55.8

638

1545

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

55.7

3788

14368

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.9

55.6

830

2215

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

55.5

5238

20817

R49.01

ICD-10 Finland

Functional dysphonia

2.0

55.5

691

1729

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.6

55.5

228

316

DFF59

NOMESCO Finland

Other assessment of balance

3.7

55.4

220

297

R10.0

ICD-10 Finland

Acute abdomen

1.9

55.3

860

2327

L60.0

ICD-10 Finland

Ingrowing nail

1.7

55.2

1237

3734

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

55.1

6801

27941

A10BB12

ATC

glimepiride; oral

1.5

55.0

1742

5728

S01.0

ICD-10 Finland

Open wound of scalp

1.5

54.9

2237

7757

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.5

54.8

1900

6374

A97

ICPC

No disease

1.3

54.7

5429

21715

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

54.7

1495

4749

N05AF03

ATC

chlorprothixene; systemic

2.1

54.7

647

1588

D06BB04

ATC

podophyllotoxin; topical

1.6

54.6

1480

4691

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

54.6

783

2061

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

54.5

1386

4324

F40.1

ICD-10 Finland

Social phobias

2.0

54.5

704

1786

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

54.3

628

1528

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

54.2

909

2520

ZX100

NOMESCO Finland

Oral

2.8

54.1

328

587

K03.00

ICD-10 Finland

Approximal wear

1.5

54.0

1922

6482

A07EA06

ATC

budesonide; oral, local oral

1.8

54.0

912

2534

K05

ICPC

Irregular heartbeat other

2.0

53.8

722

1857

L50.9

ICD-10 Finland

Urticaria, unspecified

1.8

53.8

960

2714

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

53.8

751

1959

L50.0

ICD-10 Finland

Allergic urticaria

2.1

53.7

640

1575

Angiography of the heart and coronary arteries

1.6

53.7

1519

4865

C09AA02

ATC

enalapril; systemic

1.3

53.7

5578

22437

D10

ICPC

Vomiting

1.5

53.5

1731

5718

I49.5

ICD-10 Finland

Sick sinus syndrome

1.8

53.3

887

2453

S82

ICPC

Naevus/mole

1.3

53.2

3840

14692

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

53.2

1970

6700

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.1

53.2

281

463

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

53.2

2823

10282

N81.1

ICD-10 Finland

Cystocele

1.6

53.1

1274

3915

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.9

53.1

304

526

S22

ICPC

Nail symptom/complaint

1.6

53.1

1637

5350

R19.5

ICD-10 Finland

Other faecal abnormalities

2.6

53.0

360

686

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.1

53.0

568

1340

S06

ICPC

Rash localized

1.6

53.0

1407

4437

R75

ICPC

Sinusitis acute/chronic

1.7

53.0

1206

3656

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

52.9

934

2632

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.9

52.8

813

2193

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

52.6

2210

7710

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

52.6

4304

16770

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.1

52.6

615

1503

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

52.5

485

1074

A07EC02

ATC

mesalazine; oral, rectal

1.6

52.5

1492

4783

H60.3

ICD-10 Finland

Other infective otitis externa

2.1

52.5

574

1366

D01AE16

ATC

amorolfine; topical

1.4

52.5

3150

11711

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

52.5

1303

4041

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

52.4

1905

6454

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.4

52.3

2493

8905

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

52.3

420

872

H81.0

ICD-10 Finland

Ménière disease

2.2

52.3

510

1157

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

52.2

385

766

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

52.2

837

2288

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

52.1

3272

12254

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

52.0

632

1567

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.0

52.0

659

1660

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

51.9

2097

7259

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.9

51.8

813

2207

L04AD01

ATC

ciclosporin; systemic

2.4

51.7

430

908

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

51.7

1417

4504

B03XA02

ATC

darbepoetin alfa; parenteral

2.3

51.6

466

1022

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.8

51.6

847

2333

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.7

51.5

342

644

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

51.5

2683

9737

Z03.4

ICD-10 Finland

Observation for suspected myocardial infarction

27.4

51.5

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.7

51.4

1052

3097

JN4BD

NOMESCO Finland

Extensive body CT

1.4

51.3

2694

9791

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

51.2

1180

3588

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

51.2

859

2382

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.4

51.1

431

916

J01MA01

ATC

ofloxacin; systemic

1.4

51.1

2240

7878

N06AG02

ATC

moclobemide; oral

1.7

51.0

1019

2978

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

2.0

51.0

680

1745

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.7

50.9

1040

3059

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

50.9

2300

8134

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

2.4

50.9

406

840

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.5

50.8

395

807

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.9

50.8

757

2019

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.8

50.8

970

2799

E86

ICD-10 Finland

Volume depletion

2.0

50.7

618

1534

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

50.7

560

1338

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.8

50.7

852

2364

H60.8

ICD-10 Finland

Other otitis externa

1.9

50.7

762

2039

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

50.6

996

2899

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

50.6

1674

5558

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

50.6

606

1495

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.0

50.5

634

1592

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

50.4

1496

4845

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.2

50.4

252

401

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

50.3

1337

4217

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

50.3

512

1183

WX199

NOMESCO Finland

Other local analgesia

1.9

50.3

767

2062

N06AA10

ATC

nortriptyline; systemic

2.2

50.3

487

1102

R32

ICD-10 Finland

Unspecified urinary incontinence

2.1

50.2

581

1414

TDA90

NOMESCO Finland

Removal wax from ear

2.8

50.2

305

547

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

50.1

877

2464

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.0

50.1

627

1572

FN1AD

NOMESCO Finland

CT of coronary arteries

2.5

50.0

368

732

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.4

50.0

425

907

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.1

50.0

584

1427

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.3

49.9

454

999

R06.4

ICD-10 Finland

Hyperventilation

2.5

49.9

371

742

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

49.8

1294

4060

WX882

NOMESCO Finland

High dependency care

2.0

49.7

664

1705

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

2.2

49.7

482

1091

J01FA15

ATC

telithromycin; oral

1.4

49.7

2703

9882

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

49.7

1281

4011

M03BX01

ATC

baclofen; systemic

2.3

49.6

445

973

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.3

49.6

450

989

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

49.6

1603

5294

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

89.1

49.6

J20

ICD-10 Finland

Acute bronchitis

1.4

49.5

2789

10256

A27

ICPC

Fear of other disease NOS

1.7

49.5

1180

3620

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.6

49.5

1287

4037

C02AC05

ATC

moxonidine; oral

1.7

49.5

1068

3190

NH1AD

NOMESCO Finland

Ankle and foot CT

2.1

49.5

560

1351

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.6

49.4

202

279

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.6

49.4

1417

4553

C08CA02

ATC

felodipine; oral

1.4

49.4

2416

8670

K04.09

ICD-10 Finland

Pulpit UNS

1.6

49.4

1252

3903

I20.09

ICD-10 Finland

Unstable angina

1.6

49.3

1386

4432

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.7

49.2

1014

2991

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

49.1

700

1840

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.2

49.0

509

1186

R06AX26

ATC

fexofenadine; oral

1.5

49.0

1855

6337

J01FA01

ATC

erythromycin; systemic

1.3

48.9

4373

17238

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.1

48.7

519

1222

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.3

48.7

435

950

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.8

48.5

190

254

G43.3

ICD-10 Finland

Complicated migraine

2.4

48.5

398

835

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

48.4

1203

3731

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

2.8

48.4

302

550

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.0

48.4

654

1687

K85

ICPC

Elevated blood pressure

1.3

48.3

4086

15981

XA400

NOMESCO Finland

EEG

4.8

48.3

142

148

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.5

48.3

367

742

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

5.1

48.2

134

132

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.5

48.2

1561

5157

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.8

48.2

887

2532

SBB10

NOMESCO Finland

Dental impressions

1.5

48.1

1962

6802

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

48.1

1183

3659

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

48.0

2227

7913

KHV, ,

NOMESCO Finland

4.1

48.0

167

203

M05BX04

ATC

denosumab; parenteral

1.6

47.9

1221

3811

H53.4

ICD-10 Finland

Visual field defects

2.2

47.9

477

1092

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.4

47.8

218

326

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

47.8

1215

3790

M54

ICD-10 Finland

Dorsalgia

1.3

47.8

3756

14541

T82

ICPC

Obesity

1.7

47.7

1015

3020

SPAT1236

SPAT

Informing family of child’s disability

2.2

47.7

469

1068

I25.2

ICD-10 Finland

Old myocardial infarction

1.5

47.6

1784

6080

205

Kela drug reimbursment

Chronic hypertension

1.2

47.6

7862

33279

R49.08

ICD-10 Finland

Other specified dysphonia

2.2

47.6

472

1079

EMB10

NOMESCO Finland

Tonsillectomy

1.5

47.6

1681

5660

I20.00

ICD-10 Finland

Unstable angina

1.9

47.4

718

1926

IHZ05

NOMESCO Finland

Therapeutic conversation

9.2

47.4

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.7

47.3

941

2747

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.1

47.2

521

1245

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.2

47.2

447

1002

N19

ICD-10 Finland

Unspecified kidney failure

1.8

47.2

852

2418

R4120

NOMESCO Finland

Occupational therapy

1.5

47.1

1698

5741

SPAT1210

SPAT

Application of cast or individual aid

1.7

47.0

1000

2976

S70.0

ICD-10 Finland

Contusion of hip

1.7

46.8

967

2854

P18

ICPC

Medication abuse

4.0

46.8

169

212

Z72.2

ICD-10 Finland

Drug use

4.4

46.7

150

170

R03AC13

ATC

formoterol; inhalant

1.6

46.7

1227

3860

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.1

46.5

162

197

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.8

46.5

750

2054

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.1

46.4

511

1220

C10AA03

ATC

pravastatin; oral

1.5

46.4

1642

5531

RF210, ,

NOMESCO Finland

1.9

46.4

662

1741

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.7

46.3

915

2666

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.9

46.3

634

1643

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.0

46.3

586

1476

J01MA06

ATC

norfloxacin; oral

1.3

46.3

3555

13715

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.8

46.3

813

2288

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

7.2

46.2

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

46.2

1215

3823

K08.3

ICD-10 Finland

Retained dental root

1.4

46.2

2022

7108

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

46.2

1022

3075

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

46.1

570

1423

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.5

46.1

1838

6344

WX400

NOMESCO Finland

Inhalation anesthesy

1.7

46.1

1074

3276

C07AG02

ATC

carvedilol; oral

1.5

46.1

1441

4724

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

46.0

793

2218

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.5

46.0

1515

5024

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

1.9

46.0

638

1661

N80

ICPC

Head injury other

2.2

46.0

457

1046

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

45.9

9078

39090

F05

ICPC

Visual disturbance other

1.9

45.9

681

1815

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

45.9

617

1589

D03

ICPC

Heartburn

1.8

45.8

841

2398

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

45.8

701

1887

F32

ICD-10 Finland

Depressive episode

1.5

45.8

1483

4900

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.1

45.8

543

1335

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

45.7

1126

3484

N29

ICPC

Neurological sympt/complt other

2.3

45.7

427

951

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.8

45.7

817

2311

G50.1

ICD-10 Finland

Atypical facial pain

2.4

45.7

374

784

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.7

45.6

930

2735

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.3

45.6

425

946

XQ899

NOMESCO Finland

Other assessment of skin

7.3

45.6

Z51.6

ICD-10 Finland

Desensitization to allergens

2.7

45.5

301

566

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.1

45.4

499

1190

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.5

45.4

1510

5017

S19

ICPC

Skin injury other

1.7

45.4

980

2929

IBA03

NOMESCO Finland

Psychotherapy evaluation

3.1

45.3

233

378

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

2.3

45.3

415

917

M89.0

ICD-10 Finland

Algoneurodystrophy

3.5

45.2

196

283

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.1

45.2

519

1260

Z31.5

ICD-10 Finland

Genetic counselling

1.6

45.2

1381

4504

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.4

45.1

366

764

F93.89

ICD-10 Finland

Other childhood emotional disorders

3.7

45.1

179

242

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

45.1

963

2869

Z03

ICPC

Housing/neighbourhood problem

4.0

45.1

164

207

Z30.2

ICD-10 Finland

Sterilization

1.4

45.0

2656

9839

Z51.0

ICD-10 Finland

Radiotherapy session

2.8

45.0

270

481

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.9

44.9

165

210

R08

ICPC

Nose symptom/complaint other

1.8

44.9

857

2473

S01EE05

ATC

tafluprost; ophthalmic

1.8

44.8

746

2064

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.7

44.8

954

2840

XKC03

NOMESCO Finland

Water cystometry

1.9

44.8

620

1613

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

44.8

730

2007

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.5

44.7

346

706

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.0

44.7

594

1523

ZZA00

NOMESCO Finland

Split skin graft

1.9

44.7

675

1810

K28

ICPC

Limited function/disability (K)

2.1

44.7

477

1125

160

Kela drug reimbursment

exenatide

2.2

44.6

430

971

S09

ICPC

Infected finger/toe

1.8

44.6

784

2207

DHB50

NOMESCO Finland

Turbinoplasty

1.9

44.6

655

1740

K05.18

ICD-10 Finland

Chronic gingivitis

1.5

44.5

1889

6600

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

44.5

1544

5178

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.3

44.4

404

890

V03AE01

ATC

polystyrene sulfonate; oral

2.6

44.4

303

580

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.2

44.3

432

981

M65.3

ICD-10 Finland

Trigger finger

1.6

44.3

1080

3334

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.9

44.2

703

1917

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

44.2

595

1533

L01BA01

ATC

methotrexate; systemic

1.7

44.1

866

2519

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.8

44.1

745

2071

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

44.1

682

1843

ZX112

NOMESCO Finland

Subcutaneous

2.1

44.0

466

1095

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

1.7

44.0

999

3026

S08

ICPC

Skin colour change

1.6

44.0

1253

4019

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.3

44.0

391

852

B80

ICPC

Iron deficiency anaemia

2.0

44.0

554

1393

N89

ICPC

Migraine

1.7

44.0

895

2631

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.2

43.9

212

330

S01EC04

ATC

brinzolamide; ophthalmic

1.8

43.8

825

2371

S20.2

ICD-10 Finland

Contusion of thorax

1.5

43.7

1391

4577

GX2C5

NOMESCO Finland

Short-lasting oximetry

6.3

43.7

101

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.9

43.7

250

433

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.1

43.7

220

352

G01AA10

ATC

clindamycin; vaginal

1.3

43.6

3570

13892

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

43.4

636

1688

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

43.4

920

2736

K99

ICPC

Cardiovascular disease other

1.9

43.3

593

1537

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.6

43.3

1064

3292

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.6

43.2

307

600

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.4

43.2

362

768

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.4

43.1

365

778

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.0

43.1

571

1463

Y94.0

ICD-10 Finland

Accident at home

2.2

43.1

433

996

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.8

43.0

774

2195

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

2.5

43.0

320

641

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

42.9

930

2783

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.0

42.9

565

1445

CS2P4

NOMESCO Finland

Optic nerve head imaging

3.7

42.7

171

233

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

2.8

42.7

257

459

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

3.4

42.6

190

280

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.0

42.6

525

1310

A10BJ02

ATC

liraglutide; parenteral

1.9

42.6

639

1710

XJC10

NOMESCO Finland

Oesophageal pH monitoring

4.6

42.5

131

143

Z49.2

ICD-10 Finland

Other dialysis

3.8

42.5

166

222

L50.3

ICD-10 Finland

Dermatographic urticaria

2.2

42.5

405

911

L74

ICPC

Fracture: hand/foot bone

2.1

42.4

498

1220

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.0

42.4

515

1278

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

42.4

858

2519

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.6

42.3

286

545

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

4.2

42.2

143

170

A92

ICPC

Allergy/allergic reaction NOS

1.8

42.2

727

2034

A12AA04

ATC

calcium carbonate; oral

2.4

42.1

346

727

P19

ICPC

Drug abuse

2.8

42.1

250

443

R2110

NOMESCO Finland

Giving the first information

1.5

42.1

1746

6074

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

42.0

570

1473

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

42.0

1863

6564

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.1

42.0

212

340

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.9

42.0

621

1654

R07.2

ICD-10 Finland

Precordial pain

2.1

41.9

476

1151

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.2

41.9

430

998

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.7

41.9

271

504

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.9

41.9

662

1802

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

4.8

41.6

123

129

JN4AD

NOMESCO Finland

Body CT examination

1.4

41.6

2491

9247

RS221, ,

NOMESCO Finland

2.4

41.6

331

685

N28

ICPC

Limited function/disability (N)

2.4

41.6

342

719

D18

ICPC

Change in faeces/bowel movements

2.0

41.5

539

1371

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.8

41.5

725

2037

SGC10

NOMESCO Finland

Pulp capping

1.4

41.5

2727

10273

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

41.5

1485

5013

OAB93, ,

SPAT

1.5

41.5

1631

5613

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

41.5

1651

5696

K03.80

ICD-10 Finland

Irradiated enamel

1.5

41.5

1372

4554

A03CA02

ATC

clidinium and psycholeptics; oral

1.5

41.4

1318

4337

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.2

41.4

430

1003

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.3

41.4

359

774

N18

ICPC

Paralysis/weakness

2.2

41.3

420

971

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

41.3

1260

4107

Z06

ICPC

Unemployment problem

3.1

41.3

217

357

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.3

41.3

376

829

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

41.2

1200

3869

J01DC02

ATC

cefuroxime; systemic

1.5

41.2

1451

4881

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.6

41.2

298

588

A10AB06

ATC

insulin glulisine; parenteral

3.0

41.2

229

390

I95.9

ICD-10 Finland

Hypotension, unspecified

2.4

41.2

347

738

N05AB03

ATC

perphenazine; systemic, rectal

1.7

41.2

855

2528

R41.0

ICD-10 Finland

Disorientation, unspecified

1.8

41.1

744

2113

P02

ICPC

Acute stress reaction

1.5

41.1

1379

4591

ZX114

NOMESCO Finland

Intramuscular

2.4

41.1

325

671

N06DX01

ATC

memantine; oral

1.5

41.1

1752

6127

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

41.1

1739

6073

WX702

NOMESCO Finland

Supraglottic ventilation device

1.5

41.0

1431

4806

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

2.4

41.0

338

712

H65.2

ICD-10 Finland

Chronic serous otitis media

2.5

41.0

304

608

I49.1

ICD-10 Finland

Atrial premature depolarization

1.7

41.0

798

2317

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

40.9

646

1758

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.8

40.9

676

1867

M01AH03

ATC

valdecoxib; oral

1.5

40.9

1528

5205

R78

ICPC

Acute bronchitis/bronchiolitis

2.1

40.8

471

1146

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.3

40.8

3356

13063

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.1

40.8

474

1157

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.0

40.7

521

1318

P27

ICPC

Fear of mental disorder

2.5

40.7

312

634

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.2

40.7

384

860

M77.4

ICD-10 Finland

Metatarsalgia

1.5

40.7

1499

5091

137

Kela drug reimbursment

Uraemia requiring dialysis

3.2

40.7

201

318

XCD20

NOMESCO Finland

Photoangiography of eye

2.3

40.6

382

854

C03AA03

ATC

hydrochlorothiazide; oral

1.4

40.6

2263

8301

Z11.2

ICD-10 Finland

Special screening examination for other bacterial diseases

74.0

40.5

C08DA01

ATC

verapamil; systemic

1.6

40.5

991

3062

A13

ICPC

Concern/fear medical treatment

2.3

40.5

379

846

C61

ICD-10 Finland

Malignant neoplasm of prostate

1.4

40.4

2553

9557

TND32

NOMESCO Finland

Custom moulded splint, wrist or hand

2.6

40.4

286

558

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.7

40.4

905

2732

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

3.5

40.4

173

248

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.6

40.4

164

226

J04.0

ICD-10 Finland

Acute laryngitis

1.7

40.4

931

2833

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.5

40.3

307

622

B34.9

ICD-10 Finland

Viral infection, unspecified

1.7

40.3

784

2276

EMAK, ,

NOMESCO Finland

1.7

40.2

927

2820

L20

ICPC

Joint symptom/complaint NOS

1.7

40.2

865

2584

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.8

40.1

252

461

S01EA05

ATC

brimonidine; ophthalmic

1.9

40.0

550

1428

B05DA

ATC

Isotonic solutions

3.6

40.0

165

230

S62.6

ICD-10 Finland

Fracture of other finger

1.5

40.0

1236

4041

Z00.5

ICD-10 Finland

Examination of potential donor of organ and tissue

22.4

40.0

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

39.9

2659

10036

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

39.9

2253

8284

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

2.3

39.9

355

775

A04AA01

ATC

ondansetron; systemic, rectal

1.4

39.8

1964

7055

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40761535) Cells panel - Urine sediment

3733

9163

2.13

322.61

3.6

2.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6354

18919

1.79

316.45

2.7

2.1

2.35

2.33

g/l

1.72

5927

17296

(3020682) Albumin/Creatinine [Ratio] in Urine

11993

41674

1.59

307.65

4.1

3.5

10.78

8.60

mg/mmol

3.49

7899

26153

(3023368) Bacteria identified in Blood by Culture

11164

37908

1.62

307.65

4.5

4.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

17663

61099

1.72

307.65

5.3

4.3

35.77

35.61

g/l

2.77

16509

56386

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

39897

172723

2.02

307.65

15.7

10.5

22.60

24.89

mg/l

30.80

32391

130985

(3001604) Monocytes [#/volume] in Blood

21421

73837

1.83

307.65

6.4

5.0

0.58

0.59

e9/l

1.53

18940

62232

(3013826) Glucose [Moles/volume] in Serum or Plasma

24120

87198

1.79

307.65

5.2

4.1

6.72

6.63

mmol/l

7.28

22587

80051

(3020564) Creatinine [Moles/volume] in Serum or Plasma

41333

185886

1.93

307.65

17.6

12.2

78.49

76.21

umol/l

31.09

41321

185785

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

15553

52168

1.74

307.65

3.7

3.0

93.41

61.91

ng/l

0.45

10302

32560

(3019550) Sodium [Moles/volume] in Serum or Plasma

40053

172747

2.07

307.65

17.6

12.0

139.60

139.67

mmol/l

7.49

39132

167269

(3019309) Folate [Moles/volume] in Red Blood Cells

7727

22883

1.83

307.65

1.8

1.7

1150.55

1208.19

nmol/l

5.48

5912

17110

(40758558) Short blood count panel - Blood

10767

36095

1.64

307.65

7.3

6.1

—

(3022096) Basophils/100 leukocytes in Blood

19402

67865

1.74

307.65

6.6

5.2

0.67

0.66

2.31

18170

63160

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5411

14375

2.00

307.65

7.4

5.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

9869

32090

1.69

307.65

1.3

1.2

1.87

1.75

u/ml

0.33

2630

9244

(3018010) Neutrophils/100 leukocytes in Blood

20399

72309

1.73

307.65

6.5

5.0

56.99

57.15

1.04

19214

67791

(3019069) Monocytes/100 leukocytes in Blood

20121

70628

1.75

307.65

6.9

5.4

8.54

0.04

18922

66036

(3023103) Potassium [Moles/volume] in Serum or Plasma

40148

173466

2.07

307.65

17.7

12.1

3.97

3.96

mmol/l

9.34

39145

167574

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

17048

57757

1.75

307.65

2.4

2.0

75.56

75.52

nmol/l

0.05

15513

52239

(3019225) pH of Specimen

4398

9931

2.35

307.65

4.6

3.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

30996

117819

1.93

307.65

8.0

6.4

77.71

78.04

u/l

0.51

29467

110158

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

12867

38830

1.91

307.65

2.3

1.9

228.03

227.98

u/l

0.00

12132

36194

(3012516) Albumin [Mass/volume] in Urine

11413

39417

1.60

307.65

3.5

3.0

429.08

331.08

mg/l

1.30

7561

24986

(3037467) Urinalysis macro (dipstick) panel - Urine

28007

109528

1.69

307.65

4.5

3.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

20125

70004

1.77

307.65

6.9

5.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10958

33357

1.84

307.65

2.4

2.0

2.96

2.89

mg/l

1.77

9451

28190

(3019198) Lymphocytes [#/volume] in Blood

21991

77135

1.80

307.65

6.5

5.0

1.94

e9/l

0.07

19815

67023

(3013115) Eosinophils [#/volume] in Blood

22193

76594

1.85

307.65

6.7

5.2

0.19

e9/l

1.07

19813

65961

(3013707) Erythrocyte sedimentation rate by Westergren method

30106

114130

1.89

307.65

4.3

3.2

11.46

11.24

mm/h

1.72

28122

105159

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19238

73411

1.53

307.65

2.7

2.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6964

20491

1.83

307.65

1.9

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3868

9107

2.23

307.65

2.4

2.0

7.67

8.55

ug/l

1.01

3367

7952

(3031040) Bacteria [#/volume] in Urine by Automated count

26774

102736

1.71

307.65

4.6

3.6

1520.85

1220.67

e6/l

0.33

276

2105

(3007164) IgA [Mass/volume] in Serum or Plasma

8767

27735

1.72

307.65

1.5

1.4

2.38

2.39

g/l

0.06

5480

17573

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8133

25562

1.72

307.65

3.9

3.1

568.18

603.72

ng/l

0.10

6031

19287

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13611

42713

1.84

307.65

2.8

2.3

57.70

65.56

u/l

2.34

12669

39267

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

36481

153213

1.85

307.65

4.9

3.9

2.18

mu/l

0.00

33889

140319

(3013512) EKG study

11447

38382

1.65

307.65

4.0

3.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

36963

163005

1.63

307.65

4.5

3.8

5.95

5.81

mmol/l

67.42

34105

149081

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5764

16532

1.85

307.65

6.8

4.7

1.05

1.03

mmol/l

3.71

5365

15361

(3002030) Lymphocytes/100 leukocytes in Blood

20646

73834

1.71

307.65

6.7

5.2

28.20

28.19

0.04

19459

69301

(3009508) Creatinine [Moles/volume] in Urine

12865

43365

1.67

307.65

3.5

2.9

7.84

8.10

mmol/l

5.80

11030

36770

(3001122) Ferritin [Mass/volume] in Serum or Plasma

18710

68633

1.61

307.65

3.0

2.5

119.24

121.55

ug/l

0.48

17454

63732

(3013650) Neutrophils [#/volume] in Blood by Automated count

24158

87453

1.79

307.65

9.5

8.0

4.09

4.16

e9/l

3.63

21466

74337

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

35051

151563

1.62

307.65

5.9

4.6

39.96

38.73

mmol/mol

82.97

32811

140467

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

18138

61897

1.76

307.65

6.6

5.3

1.21

mmol/l

0.03

16621

56490

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

36706

159767

1.68

307.65

13.8

10.4

84.20

84.63

ml/min/173m2

2.75

30841

127352

(3006315) Basophils [#/volume] in Blood

21483

73965

1.84

307.65

6.4

5.0

0.04

e9/l

1.43

18982

62278

(40761511) CBC panel - Blood by Automated count

40798

184627

1.80

307.65

14.5

10.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

18908

64643

1.78

307.65

15.3

12.6

1.27

1.23

inr

3.67

5383

20556

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5186

13990

1.96

307.65

4.3

3.8

31.95

31.71

0.73

3723

9668

(3022948) Iron [Moles/volume] in Serum or Plasma

6902

20514

1.80

307.65

2.7

2.1

13.25

13.51

umol/l

1.75

6469

19002

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

31030

124330

1.73

307.65

4.1

3.4

14.72

14.66

pmol/l

3.91

28581

112419

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13997

50455

1.56

307.65

3.5

2.7

34.12

34.17

u/l

0.01

13329

47617

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

20340

67094

1.91

307.65

7.4

5.4

1.21

mmol/l

1.31

17729

54178

(40768797) Stomach Pathology biopsy report

5970

16374

1.95

307.65

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

9350

29616

1.73

307.65

1.6

1.4

20.03

19.90

nmol/l

0.30

8152

25507

(3006504) Eosinophils/100 leukocytes in Blood

20020

70126

1.75

307.65

6.6

5.2

2.88

2.82

2.73

18787

65489

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

16707

53861

1.86

307.65

2.0

1.7

96.30

94.95

pmol/l

2.73

9108

27794

(3026008) Bacteria identified in Urine by Culture

12020

42110

1.58

307.65

3.1

2.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9636

30777

1.72

307.65

1.9

1.6

1.14

1.25

mg/l

1.83

7218

23497

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

41370

187362

1.87

307.65

11.1

8.0

27.13

27.03

u/l

0.32

40088

180233

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

21455

74209

1.82

307.65

6.4

5.5

11.30

11.97

umol/l

9.07

20376

70007

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11337

34279

1.87

307.65

3.2

2.7

1532.47

1468.47

ng/l

0.60

9607

28956

(3015377) Calcium [Moles/volume] in Serum or Plasma

13196

47848

1.53

304.74

3.2

3.5

2.35

mmol/l

4.03

11606

42835

(3048689) Calprotectin [Mass/mass] in Stool

5755

16860

1.81

300.88

2.4

2.5

126.99

140.13

ug/g

1.79

4602

13470

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5934

17635

1.79

295.73

2.7

2.2

22.84

23.42

1.95

5087

15057

(3007461) Platelets [#/volume] in Blood

43241

201727

1.89

295.17

23.0

15.2

251.47

251.83

e9/l

0.50

42412

194840

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

27482

115885

1.45

294.48

3.4

2.5

48.79

44.96

u/l

8.90

25854

108986

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4209

11187

1.97

293.95

2.2

371.72

382.37

nmol/l

2.25

3849

10404

(3009542) Hematocrit [Volume Fraction] of Blood

43195

201545

1.88

291.84

23.1

15.3

40.30

40.95

9.02

40868

188423

(3010813) Leukocytes [#/volume] in Blood

43273

202053

1.89

291.00

23.0

15.1

6.79

6.69

e9/l

11.61

42336

194437

(3035941) MCH [Entitic mass]

43254

201990

1.88

289.23

22.9

15.1

30.26

30.22

3.95

42728

198593

(3024731) MCV [Entitic volume]

43254

202012

1.88

288.52

22.9

15.1

90.74

90.50

22.77

42727

198611

(3026361) Erythrocytes [#/volume] in Blood

43259

202046

1.88

288.42

23.0

15.1

4.51

4.56

e12/l

59.94

42323

194466

(3000963) Hemoglobin [Mass/volume] in Blood

43270

202143

1.88

287.48

23.1

15.2

135.77

137.08

g/l

60.09

42744

198807

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10062

34797

1.57

282.46

2.5

2.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2969

7016

2.20

279.88

4.0

3.0

5.14

kpa

0.06

2813

6662

(3037522) Nuclear Ab [Titer] in Serum

6087

18526

1.74

278.63

1.4

1.3

542.62

532.21

titre

0.13

1222

3333

(3009343) pH of Capillary blood

2925

6957

2.18

271.24

4.0

3.0

7.41

7.42

2.48

280

1442

(3044889) 12 lead EKG panel

26722

112998

1.43

270.32

3.8

3.2

—

(3022313) Gas panel - Capillary blood

2200

4617

2.46

269.13

4.1

3.1

—

(3018095) Leukocytes [#/volume] in Urine

14358

54110

1.47

268.01

4.0

3.1

88.40

99.83

e6/l

0.80

10511

35770

(40768804) Tissue Pathology biopsy report

16077

61956

1.46

267.82

2.1

1.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

36249

162679

1.51

266.19

4.0

3.4

1.31

1.28

mmol/l

10.78

33638

150383

(3044640) Blood type and Crossmatch panel - Blood

12960

48001

1.49

262.34

2.6

2.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

5286

15752

1.77

258.48

1.8

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2814

6782

2.15

252.18

4.0

3.0

1.39

1.94

mmol/l

10.24

2050

4910

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

37646

170882

1.52

251.52

4.4

3.7

4.60

4.74

mmol/l

108.59

35304

159831

(3005719) IgG [Mass/volume] in Serum or Plasma

3551

9368

1.97

251.40

2.7

2.4

10.50

10.79

g/l

2.86

3277

8450

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1929

3927

2.53

250.57

4.3

3.2

24.61

24.82

mmol/l

2.18

1783

3641

(3035350) Ketones [Presence] in Urine by Test strip

19785

79967

1.41

249.13

3.8

3.0

0.00

estimate

0.66

3809

16963

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

38165

173973

1.52

245.71

4.8

4.1

2.74

2.84

mmol/l

87.16

35647

161525

(3042936) Bacteria identified in Isolate by Culture

6115

19264

1.68

244.85

2.2

1.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6482

20777

1.65

243.02

2.3

1.9

29.81

29.95

0.99

6296

20180

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3193

8212

2.02

241.96

4.3

3.4

92.76

87.82

ng/l

1.79

2769

7044

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

37341

169591

1.50

241.68

4.4

3.7

1.43

1.45

mmol/l

24.37

34873

157780

(3011397) Hemoglobin [Presence] in Urine by Test strip

9643

34046

1.53

241.18

3.8

2.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3991

11119

1.87

240.78

8.8

5.8

9.77

9.63

mmol/l

0.50

3790

10544

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6732

21917

1.63

237.04

3.7

3.1

0.82

mmol/l

2.82

6317

20506

(3002582) Erythrocytes [#/volume] in Urine

12297

45814

1.47

236.68

3.5

2.7

75.01

110.68

e6/l

1.71

9752

33139

(3009261) Glucose [Presence] in Urine by Test strip

19904

81022

1.40

236.22

3.8

3.0

0.00

estimate

1.11

3526

15839

(3021601) Nitrite [Presence] in Urine by Test strip

19719

80164

1.40

235.58

5.1

4.0

0.00

estimate

5.11

3627

16315

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1986

4253

2.40

232.33

2.1

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4833

14480

1.75

230.29

4.5

3.9

235.26

246.49

u/l

5.51

4559

13745

(3027945) Reticulocytes/100 erythrocytes in Blood

4748

14269

1.74

223.45

2.7

2.4

1.78

1.70

5.45

4186

12645

(3023520) Reticulocytes [#/volume] in Blood

3569

9813

1.89

223.25

2.6

2.5

69.83

68.47

e9/l

1.23

2760

6947

(3019150) Specific gravity of Urine by Refractometry

9179

32529

1.51

223.11

4.1

3.2

1.02

kg/l

0.36

1395

4854

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2737

6904

2.05

217.62

1.5

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

1214

2066

3.00

217.23

3.3

2.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6775

22662

1.58

211.32

1.3

1.2

11.55

11.57

u/ml

0.00

2636

9261

(3005322) IgE [Units/volume] in Serum or Plasma

3012

7962

1.96

210.67

1.3

1.2

230.56

257.45

u/ml

0.61

2801

7350

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3587

10070

1.85

210.11

2.7

2.2

67.76

69.24

ml/min/173m2

1.12

1387

4014

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7162

24309

1.56

209.74

1.3

1.2

28.84

37.20

iu/ml

3.08

2229

8006

(3017143) Hepatitis C virus Ab [Presence] in Serum

5813

18773

1.63

208.95

1.7

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

10683

39512

1.46

208.42

2.8

2.3

3669.54

5230.33

umol/l

3.61

9463

34911

(3030467) Casts [#/volume] in Urine by Automated count

11183

41757

1.45

207.50

3.4

2.7

0.38

0.47

e6/l

3.13

8805

29752

(3018418) pH of Serum or Plasma

11408

42761

1.45

207.43

4.3

3.6

7.40

4.92

1986

9826

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1811

3917

2.37

207.05

1.9

1.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4767

14661

1.70

205.75

7.8

7.2

12.41

12.63

kpa

1.71

4519

13918

(3000850) Epithelial cells [#/volume] in Urine

8691

30905

1.50

205.53

2.8

2.3

5.25

6.03

e6/l

5.02

7874

27164

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4768

14672

1.70

205.37

7.8

7.3

5.09

5.08

kpa

0.14

4513

13934

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3193

8712

1.90

203.60

1.7

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5015

15737

1.67

200.71

3.1

2.4

7.69

9.28

umol/l

4.89

4386

13499

(4146454) Self-monitoring of blood glucose

553

540

5.18

199.32

2.7

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4713

14575

1.69

198.98

1.8

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4672

14419

1.69

198.69

1.8

1.6

—

(3000494) Fungus identified in Specimen by Culture

5022

15845

1.66

196.63

1.5

1.3

—

(3012544) pH of Venous blood

4188

12578

1.73

196.06

4.3

3.3

7.38

0.01

120

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2581

6638

2.00

194.26

1.7

1.5

—

(3002032) Base excess in Venous blood by calculation

4042

12068

1.74

192.97

4.4

3.3

1.88

1.78

mmol/l

0.92

3373

10297

(3003396) Base excess in Arterial blood by calculation

4747

14827

1.67

192.80

7.8

7.2

1.11

0.90

mmol/l

2.81

3658

11882

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4055

12127

1.74

192.45

4.3

3.3

5.84

5.81

kpa

0.91

3919

11789

(3021589) Normoblasts [#/volume] in Blood

17758

72576

1.36

192.01

9.7

8.7

0.00

e9/l

0.16

14848

57749

(3045414) Leukocytes [Presence] in Urine

2050

4870

2.16

188.99

2.0

1.5

—

(3016502) Oxygen saturation in Arterial blood

4259

12999

1.71

187.94

8.3

7.7

95.69

95.64

0.20

4087

12465

(36304419) Bacteria [Presence] in Urine

10925

41249

1.43

187.57

3.3

2.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2751

7377

1.92

183.93

1.8

1.9

1.32

1.29

g/l

0.23

2537

6729

(3020630) Protein [Mass/volume] in Serum or Plasma

3375

9716

1.80

181.48

2.5

2.3

66.70

66.51

g/l

0.69

3088

8895

(3014576) Chloride [Moles/volume] in Serum or Plasma

5218

16946

1.61

181.46

7.5

7.0

104.47

mmol/l

0.00

5211

16933

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3134

8825

1.84

180.79

2.4

2.3

21.92

22.59

au/ml

0.14

232

832

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6999

24354

1.52

180.49

2.9

2.5

1.05

1.34

e6/l

1.29

4244

12015

(3015736) pH of Urine

16019

64940

1.36

178.43

3.5

2.7

5.87

5.86

0.30

1223

5911

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3456

10170

1.76

172.45

3.1

2.6

210.31

212.47

ng/l

0.09

3088

9195

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3991

12260

1.69

171.20

2.5

2.0

0.21

0.22

g/l

0.32

3738

11375

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2881

8034

1.85

170.98

1.3

1.2

53.51

52.40

au/ml

0.08

148

478

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5791

19656

1.54

165.88

2.2

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6557

22877

1.51

165.55

3.1

2.6

2.36

2.81

e6/l

2.36

3825

10589

(3022145) Colonoscopy Study observation

4701

15209

1.61

164.95

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

9242

34733

1.42

158.39

2.0

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

1249

2582

2.46

156.48

2.7

2.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5999

20772

1.51

156.11

1.9

1.6

1.48

1.37

21.05

5319

18456

(36660697) Celiac disease serology panel - Serum

3628

11127

1.69

155.85

1.2

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

3695

11405

1.68

155.00

4.5

3.6

0.91

0.99

0.75

1269

3586

(3014111) Lactate [Moles/volume] in Serum or Plasma

3757

11649

1.67

154.97

7.5

7.1

1.39

1.36

mmol/l

0.87

3645

11347

(3037121) Protein [Mass/volume] in Urine

1623

3800

2.18

154.48

3.2

3.4

0.34

0.31

g/l

0.43

705

1909

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8316

30844

1.43

152.49

1.7

24230814.37

35135558.65

pmol/l

1.04

7049

25530

(3024354) Oxygen [Partial pressure] in Venous blood

3309

9965

1.72

151.64

3.7

2.7

4.73

4.56

kpa

3.55

3189

9640

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6298

22160

1.49

151.41

2.3

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

10258

39538

1.38

150.64

4.4

3.4

90.12

90.20

0.11

9977

38591

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4083

13041

1.62

149.99

2.7

2.3

46.14

43.58

u/l

0.08

3512

11232

(3002385) Erythrocyte distribution width [Ratio]

33814

154808

1.34

149.96

18.1

12.9

15.02

14.78

0.79

33353

151057

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2029

5245

1.98

149.73

1.8

1.6

1.50

1.52

g/l

0.39

1751

4417

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1357

2990

2.31

148.44

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2729

7841

1.79

146.59

2.2

—

(3017732) Neutrophils [#/volume] in Blood

3106

9276

1.73

146.38

2.8

2.5

4.81

4.84

e9/l

0.04

2512

7881

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3874

12359

1.62

142.61

8.8

7.9

122.35

122.68

g/l

0.38

3769

11982

(3021440) Promyelocytes/100 leukocytes in Blood

3505

10938

1.66

140.48

4.6

3.6

0.10

0.13

1.11

1084

3131

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

27273

121891

1.29

136.40

3.3

3.0

—

(3026782) Osmolality of Urine

8101

30450

1.40

135.78

3.1

2.5

545.28

555.55

mosm/kgh2o

3.30

7028

25863

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1628

4021

2.07

135.47

2.4

2.2

673.92

629.65

ug/l

0.10

1524

3778

(3002179) Metamyelocytes/100 leukocytes in Blood

3361

10521

1.65

132.81

4.3

3.5

0.65

0.68

0.28

1117

3022

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1325

3040

2.22

132.10

1.4

276.28

267.99

ug/g

0.63

762

1750

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1062

2203

2.45

132.00

1.4

1.2

—

(4200892) Spirometry reversibility

2968

9074

1.68

128.00

1.4

—

(3019060) Gas panel - Arterial blood

2742

8219

1.71

126.97

5.2

4.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1904

5113

1.90

125.69

1.9

39.20

39.15

u/l

0.03

1713

4542

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6955

25802

1.41

124.32

2.8

3.2

2.44

2.45

mmol/l

7.00

6064

22342

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

647

1053

3.11

124.16

1.5

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2636

7884

1.72

122.90

7.4

6.5

24.46

24.45

mmol/l

0.05

2501

7439

(3025159) Blasts/100 leukocytes in Blood

3310

10524

1.62

122.68

4.6

3.7

0.38

0.26

0.30

885

2761

(3011288) Drugs identified in Urine by Screen method

1700

4426

1.96

122.61

3.9

2.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

643

1052

3.09

122.39

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

642

1050

3.09

122.26

1.5

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

642

1050

3.09

122.26

1.5

1.3

—

(3000330) Specific gravity of Urine by Test strip

2156

6093

1.81

121.62

3.5

3.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

659

1101

3.03

121.32

1.5

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

647

1070

3.06

121.07

1.5

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

834

1599

2.64

120.94

2.4

1.7

7.94

3.29

titre

0.59

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

15215

63758

1.29

120.64

3.9

3.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1601

4130

1.98

118.42

2.1

7.33

7.41

g/l

1.01

1455

3744

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1600

4127

1.98

118.38

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1598

4123

1.98

118.13

2.1

3.64

3.85

g/l

6.05

1454

3738

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

725

1308

2.81

117.35

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1248

2945

2.16

116.27

1.4

1.3

510.86

566.75

mg/l

1.17

1181

2818

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13045

53825

1.30

115.01

4.6

4.4

3.51

3.15

ug/l

0.35

11739

48387

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1442

3618

2.03

114.96

1.8

1.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

709

1309

2.74

110.17

2.0

1.5

2067.45

5351.11

titre

0.66

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1547

4045

1.95

110.09

1.7

1.6

309.00

296.48

titre

0.05

172

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3701

12405

1.54

109.20

1.5

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1888

5295

1.82

108.91

1.7

1.5

15.27

13.17

u/ml

0.21

137

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1730

4729

1.87

108.06

2.0

1.8

1.90

2.54

ug/l

1.17

1513

4213

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1940

5507

1.80

107.64

4.1

3.4

50.08

48.04

2.61

1917

5450

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1496

3914

1.95

106.25

2.2

2.1

2.92

3.03

g/l

3.29

1351

3530

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

794

1588

2.53

106.17

1.7

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

794

1589

2.53

106.04

1.7

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2083

6084

1.75

105.08

3.7

2.9

25.15

25.25

mmol/l

0.61

2015

5884

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1101

2581

2.17

104.17

1.3

1.2

3.79

3.70

mmol/l

1.70

1024

2431

(3013139) Helicobacter pylori Ag [Presence] in Stool

2782

8835

1.62

102.95

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1744

4868

1.83

102.03

5.6

4.5

1.70

1.68

0.24

1631

4511

(3007930) Methemoglobin/Hemoglobin.total in Blood

1726

4803

1.83

101.95

5.7

4.5

0.87

0.90

2.52

1616

4447

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7415

28683

1.35

100.54

1.7

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

504

804

3.17

99.83

3.6

2.9

56.35

57.86

0.65

423

686

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2105

6258

1.72

99.77

2.4

2.3

—

(3000991) Gas panel - Venous blood

3486

11786

1.52

98.43

9.3

7.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1126

2734

2.09

97.65

1.3

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1468

3955

1.89

95.66

2.2

2.1

10.26

10.37

g/l

0.35

1313

3550

(1001926) Buprenorphine [Presence] in Urine by Screen method

1908

5597

1.74

94.66

2.7

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1038

2471

2.13

94.57

1.5

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2526

8025

1.61

93.07

3.6

2.9

129.42

130.91

g/l

2.35

2468

7835

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2129

6475

1.68

92.82

4.7

3.5

24.02

24.12

mmol/l

0.71

2079

6335

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2661

8577

1.59

92.39

3.2

3.5

4.49

4.55

pmol/l

1.97

2374

7746

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2907

9579

1.56

91.86

2.1

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1061

2586

2.08

91.11

1.3

1.2

263.78

251.98

u/ml

0.64

656

1677

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2251

7023

1.64

89.01

2.9

2.4

0.29

e6/l

0.03

2193

6804

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1091

2715

2.04

88.76

1.4

19.59

32.09

e6/l

0.84

859

1993

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1736

5047

1.75

88.74

1.2

0.98

0.64

u/ml

0.62

144

498

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1394

3785

1.87

88.69

1.8

1.5

1.17

1.18

g/l

0.51

1318

3627

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1506

4194

1.83

88.61

1.5

1.6

5.07

2.28

iu/ml

0.31

324

883

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1091

2717

2.04

88.58

1.5

1.4

4560.39

968.67

e6/l

0.55

895

2124

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1416

3896

1.85

86.50

2.8

2.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1351

3662

1.87

86.38

1.8

1.5

0.23

0.24

g/l

0.56

1273

3496

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2435

7811

1.59

86.08

1.1

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

536

972

2.79

86.06

1.8

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1234

3262

1.92

84.96

1.3

1.2

36.72

36.99

u/ml

0.01

213

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3685

12997

1.46

84.09

2.3

2.0

12.75

12.76

nmol/l

0.02

3295

11875

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3568

12509

1.47

83.96

2.2

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

824

1882

2.22

82.93

1.7

1.5

0.78

0.85

g/l

0.72

651

1294

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1004

2487

2.05

82.67

6.8

3.7

859.19

3917.93

iu/ml

0.63

163

261

(3022621) pH of Urine by Test strip

2742

9132

1.54

82.38

3.0

2.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1664

4898

1.73

81.42

1.6

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

994

2475

2.04

80.74

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

491

880

2.82

80.50

1.8

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1217

3262

1.89

80.44

1.5

1.4

12.05

13.48

iu/ml

0.12

(3004616) Nuclear Ab [Presence] in Serum

582

1148

2.56

80.02

1.3

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

1517

4377

1.76

79.47

3.9

4.0

1.39

1.44

mmol/l

1.01

1493

4309

(3026250) Tacrolimus [Mass/volume] in Blood

281

345

4.10

79.41

37.0

31.7

7.48

ug/l

0.01

261

317

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

918

2241

2.07

78.50

1.2

7.66

16.19

u/ml

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1540

4484

1.75

78.21

1.8

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1053

2712

1.97

78.04

1.5

1.3

23.17

23.15

u/ml

0.00

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2560

8502

1.54

77.76

9.8

9.1

1.43

1.34

3.80

2540

8451

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1062

2748

1.96

77.69

1.5

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

2363

7709

1.57

77.62

2.5

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1137

3017

1.91

77.40

1.3

1.2

8.42

9.88

u/ml

0.25

187

418

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2187

7013

1.59

77.25

10.1

9.8

24.23

24.34

mmol/l

0.78

2093

6776

(3036180) Methadone [Presence] in Urine

353

528

3.37

77.05

3.2

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

758

1724

2.22

77.05

5.3

4.5

370.10

363.17

umol/l

0.58

660

1469

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8289

33655

1.28

77.01

1.6

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1684

5052

1.70

76.97

1.3

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2556

8505

1.54

76.96

9.9

9.2

0.68

0.66

1.22

2534

8460

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1830

5619

1.66

76.75

1.1

14.54

4.08

u/ml

0.40

(3029937) Albumin [Presence] in Urine by Test strip

10470

43754

1.26

76.74

4.2

3.2

0.00

estimate

0.42

3504

15463

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1123

2976

1.91

76.74

1.3

1.2

5.87

10.95

u/ml

0.76

123

274

(3034770) Mitochondria Ab [Titer] in Serum

1286

3565

1.83

76.69

1.3

1.2

695.33

1180.51

titre

1.68

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1199

3255

1.87

76.27

2.0

11.67

10.26

mg/l

2.10

1112

3081

(3028300) Cannabinoids [Presence] in Urine

2377

7803

1.56

75.97

2.6

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

1302

3636

1.82

75.86

1.3

1.2

100.83

133.99

titre

0.60

120

368

(3016879) Cocaine [Presence] in Urine

2209

7131

1.58

75.85

2.6

1.7

—

(3027008) Opiates [Presence] in Urine

2370

7779

1.56

75.78

2.3

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3781

13652

1.42

75.78

3.9

4.3

26.36

33.10

ug/l

0.48

3059

10890

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

757

1736

2.21

75.48

1.4

1.3

22.76

25.65

u/l

1.46

615

1477

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1309

3680

1.81

74.66

2.2

2.4

0.85

g/l

0.01

1147

3151

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

781

1825

2.16

74.47

3.2

2.1

1498.22

4103.11

u/ml

1.26

(3014007) Fractional oxyhemoglobin in Arterial blood

2554

8558

1.52

74.43

9.9

9.3

94.04

93.78

1.28

2545

8527

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

379

613

3.12

73.62

2.8

2.1

512.95

508.93

e6/l

0.04

305

484

(3047181) Lactate [Moles/volume] in Blood

1394

4012

1.76

73.60

6.6

4.9

1.33

1.29

mmol/l

0.78

1225

3445

(3023183) Ammonium ion [Moles/volume] in Plasma

984

2530

1.97

73.27

3.2

2.4

34.21

35.13

umol/l

0.35

914

2272

(3009214) Lutropin [Units/volume] in Serum or Plasma

1588

4760

1.70

72.77

1.5

1.3

9.01

8.89

u/l

0.14

1284

3872

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

366

584

3.16

72.61

2.8

2.2

0.21

0.23

e9/l

0.68

305

484

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1470

4317

1.73

72.44

3.3

2.9

0.32

0.35

u/ml

2.59

852

2340

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

642

1395

2.33

72.36

7.1

5.4

11.41

11.22

mg/l

0.40

584

1269

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2061

6624

1.59

72.02

2.4

2.1

5671.71

6753.41

u/l

0.79

817

2704

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

386

644

3.02

71.40

2.9

2.2

692.92

650.88

e6/l

0.57

371

615

(3003338) MCHC [Mass/volume]

33555

158246

1.22

70.84

19.9

12.9

332.87

333.20

g/l

8.43

33277

156719

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10250

43130

1.24

69.50

4.0

3.9

21.77

21.89

0.29

4634

19696

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

908

2318

1.98

68.97

1.2

3.18

7.31

u/ml

1.12

177

(3019832) Treponema pallidum Ab [Presence] in Serum

5094

19613

1.34

68.73

1.8

1.6

—

(3025941) Bacteria identified in Stool by Culture

2537

8633

1.50

68.66

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

417

747

2.81

68.50

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

417

747

2.81

68.50

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

417

747

2.81

68.50

1.8

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

764

1832

2.11

68.39

3.6

2.8

1.62

1.56

0.14

670

1635

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1201

3379

1.80

68.31

2.0

2.1

37.93

37.62

g/l

0.83

1054

2990

(3027944) Amphetamines [Presence] in Urine

2310

7755

1.52

66.57

2.4

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1936

6248

1.58

66.41

3.2

2.5

1.33

1.28

0.68

1925

6215

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1173

3305

1.80

66.40

2.1

2.2

0.03

0.02

g/l

0.62

1080

3017

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

575

1242

2.34

65.69

1.1

15.47

7.64

au/ml

—

(3043409) Potassium [Moles/volume] in Arterial blood

1292

3763

1.74

65.48

4.3

4.2

3.89

3.91

mmol/l

0.63

1278

3734

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

330

528

3.15

65.25

2.7

2.4

42.06

38.49

1.79

178

265

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

473

937

2.55

64.59

3.0

2.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2184

7301

1.52

64.13

11.1

9.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

559

1212

2.33

63.36

1.1

41.96

63.22

au/ml

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

541

1158

2.36

63.05

1.6

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

541

1160

2.35

62.82

1.6

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

953

2565

1.88

62.21

1.5

1.3

120.48

104.53

u/ml

1.72

186

614

(3011412) CD3 cells [#/volume] in Blood

496

1028

2.43

61.88

2.6

2.0

1.23

1.11

e9/l

1.73

428

919

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

248

338

3.69

61.63

2.6

2.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1882

6139

1.56

61.61

3.1

2.5

0.65

0.26

1872

6116

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

867

2274

1.93

61.06

1.3

1.2

224.00

93.33

titre

0.50

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1060

2976

1.80

60.70

1.7

1.4

—

(3020891) Body temperature

1669

5325

1.59

59.99

4.9

4.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

351

616

2.87

59.80

3.0

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

630

1477

2.15

59.67

2.5

2.4

—

(3044290) Cell count panel - Cerebral spinal fluid

974

2678

1.84

59.59

1.5

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

1288

3850

1.70

59.56

1.2

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

430

849

2.55

59.15

2.1

2.2

19.55

18.85

nmol/l

0.62

406

817

(3014765) Yersinia sp identified in Stool by Organism specific culture

1282

3844

1.69

58.61

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

437

875

2.52

58.48

1.1

255.73

261.39

mg/l

0.20

388

751

(3019420) Tryptase [Mass/volume] in Serum or Plasma

287

451

3.20

58.39

1.5

1.6

7.87

7.25

ug/l

0.29

253

398

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1115

3217

1.76

58.35

3.2

2.9

24.54

24.82

mmol/l

1.26

1097

3147

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

451

919

2.47

58.28

1.2

1.1

39.89

44.78

mg/l

1.28

386

734

(3024666) Lithium [Moles/volume] in Serum or Plasma

349

621

2.83

58.09

12.4

11.6

0.61

0.62

mmol/l

0.31

317

562

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

594

1380

2.17

57.53

1.2

—

(4062490) Immunoglobulin typing, IgG

531

1179

2.27

57.14

1.4

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

118

7.23

56.92

6.9

6.7

71.40

71.63

0.02

(3044927) Protein electrophoresis panel - Urine

434

878

2.49

56.92

1.2

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

530

1179

2.27

56.79

1.4

1.3

2.90

3.04

g/l

0.86

399

692

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1216

3628

1.70

56.61

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

823

2178

1.91

56.50

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

529

1179

2.26

56.45

1.4

1.3

0.40

0.42

g/l

0.53

398

688

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

512

1127

2.29

56.19

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1264

3822

1.68

56.03

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

548

1245

2.22

55.96

2.2

1.7

26.29

29.15

mg/l

0.47

135

390

(3020961) Endomysium IgA Ab [Titer] in Serum

2096

7148

1.49

55.90

1.1

180.83

250.91

titre

0.62

214

(3027135) IgG subclass 1 [Mass/volume] in Serum

528

1181

2.26

55.89

1.4

1.3

6.80

7.02

g/l

0.51

397

691

(3038026) Centromere Ab [Units/volume] in Serum

371

699

2.67

55.79

1.2

45.13

51.20

u/ml

0.13

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

839

2257

1.88

54.89

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

28.75

54.64

1.1

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

258

395

3.29

54.61

26.4

23.8

115.98

127.25

ug/l

1.03

207

344

(3049717) Cytology report of Urine Cyto stain

1511

4816

1.59

54.50

2.6

2.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1603

5183

1.57

54.44

1.9

1.6

39.79

40.07

nmol/l

0.17

1551

5106

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1073

3125

1.74

54.39

2.1

2.2

0.00

g/l

0.12

987

2845

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

458

974

2.37

54.20

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

473

1026

2.32

53.64

1.5

1.4

1.34

1.37

promille

0.10

364

762

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

360

684

2.65

53.33

1.2

58.63

61.77

u/ml

0.06

(3008757) Leukocyte morphology finding [Identifier] in Blood

492

1091

2.27

53.14

4.1

3.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1057

3089

1.73

52.95

2.1

2.2

0.00

g/l

-0.00

986

2837

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

360

687

2.64

52.90

1.2

39.12

46.34

u/ml

0.21

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1172

3531

1.68

52.65

3.1

3.16

4.63

ratio

0.23

105

203

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1015

2941

1.75

52.37

1.8

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

439

931

2.38

52.28

3.3

2.8

62.82

46.90

mg/l

0.46

328

643

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1198

3643

1.67

52.00

3.2

3.1

55.41

43.83

mg/l

0.50

1025

2626

(3034860) Kappa light chains.free [Mass/volume] in Serum

1196

3656

1.66

50.90

3.2

3.1

98.84

63.96

mg/l

0.35

1018

2639

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

345

658

2.64

50.77

1.2

13.52

6.84

u/ml

0.38

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1151

3488

1.67

50.61

2.0

1.8

202.20

201.42

pmol/l

0.07

1085

3332

(3003181) Sodium [Moles/volume] in Urine

739

1962

1.90

50.30

1.4

64.75

62.89

mmol/l

0.49

592

1525

(3023511) Choriogonadotropin [Units/volume] in Urine

1057

3137

1.71

50.16

1.4

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

588

1440

2.06

50.00

1.6

1.5

—

(3008898) HLA-B27 [Presence]

1627

5383

1.53

49.93

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

313

572

2.76

49.81

1.5

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1267

3954

1.62

49.77

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

413

876

2.38

49.20

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1588

5248

1.54

48.98

1.3

214.57

230.27

miu/ml

0.89

715

2544

(3036489) Thrombin time

1626

5407

1.53

48.76

2.4

1.8

21.70

21.34

1.04

1402

4694

(3021387) Prolactin [Units/volume] in Serum or Plasma

1839

6279

1.49

48.69

1.6

297.33

292.57

mu/l

0.26

1667

5575

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

140

144

4.89

48.28

1.9

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

444

984

2.27

48.07

2.6

2.0

38.61

38.09

0.27

436

970

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1342

4296

1.58

47.52

3.0

2.3

3.50

3.70

g/l

4.68

1271

4096

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

300

551

2.74

47.34

1.1

4.68

9.31

nmol/l

0.80

134

(3037756) Immunofixation for Serum or Plasma

822

2309

1.80

47.05

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

303

565

2.70

46.54

1.5

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

906

2632

1.74

46.36

1.2

40.11

47.38

u/ml

0.52

266

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

256

434

2.97

46.35

2.1

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

256

434

2.97

46.35

2.1

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1418

4633

1.55

46.00

1.5

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

737

2021

1.84

45.54

1.1

—

(3042733) HLA Ab [Presence] in Serum

205

305

3.38

45.33

4.8

5.2

—

(3014271) Vancomycin [Susceptibility]

249

421

2.98

45.29

2.9

2.7

—

(1175426) CD3 cells/100 lymphocytes in Blood

398

863

2.32

45.26

2.2

1.9

73.67

72.42

0.77

375

834

(3000475) Leukocytes [#/volume] in Synovial fluid

994

2988

1.68

45.05

1.6

1.5

15669.52

13810.00

e6/l

0.38

724

2108

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

702

1913

1.85

44.24

1.3

44.90

28.05

u/l

1.87

620

1643

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1225

3906

1.59

44.11

4.4

2.8

1.48

1.46

mg/l

0.26

1138

3605

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2865

10803

1.35

43.40

1.2

140.65

149.91

iu/ml

0.46

1046

4283

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

229

378

3.05

43.32

1.5

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1257

4051

1.57

43.27

1.1

5.11

4.83

u/ml

0.08

142

691

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

229

379

3.04

43.15

1.5

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

638

1701

1.89

42.96

1.1

1.51

g/l

0.06

578

1554

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

386

851

2.28

42.36

2.2

1.8

14.54

15.49

0.94

373

832

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

906

2701

1.70

42.34

2.6

1.5

0.86

0.82

nmol/l

0.79

723

2378

(3045424) Erythrocytes [Presence] in Urine

713

1982

1.82

42.25

1.5

1.3

—

(21494755) Public health laboratory ask at order entry panel

3828

24065

0.78

42.07

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

348

737

2.38

41.69

1.5

1.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

339

710

2.40

41.58

3.4

3.1

30.28

27.96

mu/l

0.30

317

680

(3023419) Bacteria identified in Sputum by Culture

622

1663

1.89

41.55

2.9

2.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1271

4148

1.55

41.44

3.0

2.2

182.99

187.79

1.04

1206

3936

(3027923) C peptide [Moles/volume] in Serum or Plasma

278

528

2.65

41.35

1.7

1.6

1.20

1.24

nmol/l

0.17

213

440

(3010838) Calcium [Moles/time] in 24 hour Urine

729

2057

1.79

41.17

1.8

1.9

5.01

5.39

mmol/24h

2.10

639

1864

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

373

821

2.29

41.10

2.2

1.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

270

507

2.68

41.02

1.7

1.3

22.59

29.60

umol/l

2.65

259

477

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

217

359

3.04

40.94

2.2

1.7

29.11

28.84

0.09

204

340

(3006245) CD3-CD19+ cells/100 cells in Blood

222

373

2.99

40.86

2.3

1.8

9.63

10.85

0.59

205

351

(3000492) Spirometry study

4162

16664

1.28

40.83

1.5

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

389

876

2.24

40.70

1.1

284.24

286.19

mg/l

0.17

352

795

(40760888) Immunoglobulin light chains.free panel - Serum

902

2718

1.68

40.56

3.4

3.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

605

1618

1.89

40.40

1.3

0.21

0.25

nmol/l

0.30

107

(40768443) Skin Pathology biopsy report

1745

6121

1.45

40.25

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1025

3207

1.62

39.89

2.3

2.2

131.14

117.22

ug/min

0.33

645

1921

(3026389) Candida sp identified in Specimen by Organism specific culture

630

1715

1.85

39.88

1.4

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

235

415

2.85

39.82

2.1

1.5

1.94

1.97

umol/l

0.18

223

387

(3039000) Anion gap in Blood

921

2809

1.66

39.59

8.2

5.8

11.38

11.34

mmol/l

0.13

820

2487

(3018572) Chloride [Moles/volume] in Blood

921

2810

1.66

39.53

8.2

5.8

105.09

105.02

mmol/l

0.13

820

2488

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

122

134

4.57

39.38

1.4

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1381

4652

1.50

38.98

2.7

2.0

92.84

91.87

0.78

1332

4453

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

198

319

3.12

38.98

2.4

1.9

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

6.83

38.53

1.0

0.12

0.11

u/ml

0.03

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

386

891

2.18

38.16

1.3

1.2

2.02

2.11

mmol/l

0.70

360

829

(3024928) Oxygen saturation in Venous blood

900

2758

1.65

38.01

3.5

2.8

—

(40761536) Microorganisms panel - Urine sediment

2803

18108

0.76

37.92

4.3

3.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2269

8425

1.37

37.79

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1037

3302

1.59

37.58

3.8

2.9

8.39

8.31

kpa

0.80

1007

3227

(1761868) Lipid panel - Serum or Plasma

13045

72491

0.86

37.58

2.7

2.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

493

1262

1.97

37.37

3.1

3.3

4.79

9.52

nmol/l

0.55

478

1230

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

595

1627

1.84

37.18

1.3

0.59

2.35

nmol/l

1.11

574

1557

(3008037) Lactate [Moles/volume] in Venous blood

905

2801

1.63

36.79

3.1

2.7

1.57

1.64

mmol/l

1.21

882

2743

(3016650) Hepatitis A virus Ab [Presence] in Serum

792

2372

1.69

36.46

1.1

—

(3024932) HLA-DR beta [Type]

190

312

3.06

36.34

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

285

587

2.44

36.27

1.4

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

292

610

2.41

36.09

1.0

42.52

41.83

ng/l

0.08

191

470

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

294

618

2.39

35.87

1.5

1.4

6.36

5.97

u/l

0.22

256

525

(3024471) HLA-A [Type]

193

323

3.00

35.82

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

672

1933

1.75

35.67

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

289

605

2.40

35.57

1.0

299.18

334.64

ng/l

1.01

194

474

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

244

471

2.61

35.30

2.4

1.6

146.76

109.98

umol/l

0.99

124

225

(3014148) Varicella zoster virus Ab [Titer] in Serum

675

1951

1.75

35.25

1.2

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

290

611

2.39

35.22

1.0

760.72

712.06

ng/l

0.83

191

455

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

640

1832

1.76

34.55

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

10599

47201

1.16

34.36

3.3

2.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

544

1485

1.85

34.22

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

193

333

2.91

34.10

2.3

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

193

333

2.91

34.10

2.3

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

194

340

2.87

33.40

2.3

1.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

158

244

3.25

33.25

3.7

2.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

470

1234

1.92

33.23

2.5

2.7

1.44

1.30

g/24h

0.43

243

672

(21494434) Karyotype in Bone marrow

363

867

2.11

33.10

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1078

3567

1.53

33.10

1.4

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

296

649

2.29

33.02

3.0

3.7

101.71

130.56

nmol/l

0.84

290

640

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

741

2241

1.67

32.95

1.5

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

684

2035

1.70

32.32

1.5

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

295

653

2.27

32.23

1.1

1.05

1.11

u/l

0.51

132

309

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1296

4487

1.46

32.00

1.9

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

426

1098

1.95

31.77

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

345

822

2.11

31.68

1.6

1.3

—

(3023410) Appearance of Cerebral spinal fluid

494

1343

1.85

31.52

1.7

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

127

175

3.65

31.38

2.2

2.0

15.73

17.09

umol/l

0.53

127

175

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1514

5426

1.41

31.07

1.3

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

165

275

3.02

30.91

2.2

1.7

179.75

1558.89

e6/l

0.83

135

(3027456) Digoxin [Moles/volume] in Serum or Plasma

717

2188

1.65

30.86

3.1

3.0

0.81

nmol/l

0.00

518

1732

(3008295) Osmolality of Serum or Plasma

463

1242

1.88

30.78

1.5

1.4

281.11

279.40

mosm/kgh2o

0.68

360

977

(40757494) Bilirubin.total [Moles/volume] in Blood

261

562

2.34

30.35

2.4

2.0

26.21

51.49

umol/l

1.55

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

174

303

2.89

30.34

1.9

1.3

20691.92

2159.61

u/ml

0.52

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

738

2284

1.63

30.09

1.9

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

351

860

2.05

30.05

14.1

11.2

837.11

1998.29

nmol/l

0.50

331

826

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

615

1814

1.71

30.01

3.1

2.5

498.26

709.56

u/ml

0.18

610

1775

(3002256) Pathology report gross observation

4956

20930

1.21

29.38

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7232

31589

1.17

29.31

2.9

2.8

0.74

0.79

ug/l

2.73

4684

19303

(3003888) Timothy IgE Ab [Units/volume] in Serum

922

3032

1.54

29.16

1.1

6.14

5.80

u/ml

0.21

517

1474

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

766

2413

1.60

29.12

1.1

13373.71

815.22

iu/ml

0.53

186

514

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

706

2181

1.63

29.01

1.3

1.2

4.51

3.94

u/ml

0.39

304

997

(3038515) Glucose [Moles/volume] in Venous blood

839

2705

1.57

28.94

3.3

2.7

7.44

7.73

mmol/l

1.80

821

2654

(3052851) Hemolysis interference index of Serum or Plasma

1242

4349

1.44

28.94

3.3

2.9

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

359

904

2.00

28.62

21.1

16.2

1444.17

3071.98

nmol/l

0.47

346

871

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

321

775

2.08

28.57

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

480

1337

1.81

28.44

1.2

36.13

21.57

nmol/l

—

(3048879) Bone marrow aspiration report

133

204

3.28

28.36

2.1

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

416

1112

1.88

28.00

1.3

1.50

1.41

nmol/l

0.88

375

1005

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

337

839

2.02

27.72

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

316

768

2.07

27.68

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

658

2026

1.64

27.42

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

9560

42864

1.15

27.13

1.7

1.6

1.42

1.36

mmol/l

6.46

8353

35070

(3017704) Immunofixation for Urine

235

509

2.32

27.05

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

662

2049

1.63

27.04

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

421

1144

1.85

26.99

3.7

—

(3010503) CD19 cells [#/volume] in Blood

289

687

2.12

26.79

3.0

2.2

0.22

0.21

e9/l

0.02

276

671

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1009

3451

1.48

26.55

1.1

2.29

2.38

u/ml

0.09

538

1618

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

294

707

2.09

26.48

2.8

1.7

96.46

97.91

0.28

275

659

(3039162) Centromere protein B Ab [Units/volume] in Serum

528

1555

1.71

25.98

1.3

1.2

60.20

49.27

u/ml

0.35

104

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

297

724

2.06

25.85

1.5

24.90

25.66

u/ml

0.08

149

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1051

3644

1.46

25.82

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1325

4794

1.40

25.79

3.5

3.6

3108.84

2917.60

u/ml

0.03

1141

4130

(3042517) Benzodiazepines panel - Urine

106

4.17

25.78

2.6

3.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

635

1969

1.63

25.78

1.5

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

183

361

2.55

25.57

1.5

1.4

14.89

15.05

pmol/l

0.08

149

311

(3022689) Creatine [Moles/volume] in Urine

155

281

2.77

25.32

1.5

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

209

443

2.37

25.24

2.2

1.4

28.78

29.32

umol/l

0.27

203

423

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

7.00

25.17

3.1

2.3

2.43

2.47

mg/l

0.03

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

531

1581

1.69

25.15

1.1

2.03

2.01

iu/ml

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

208

442

2.37

24.99

1.1

423.27

406.23

ng/l

0.03

115

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

270

643

2.11

24.96

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

708

2274

1.57

24.90

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

878

2958

1.50

24.89

1.1

1.03

1.22

u/ml

0.34

410

1166

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

720

2327

1.56

24.66

1.3

1.2

3.23

3.90

u/ml

0.42

235

820

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

504

1488

1.71

24.62

2.4

2.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

424

1190

1.79

24.60

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

501

1481

1.70

24.37

1.5

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1002

3484

1.45

24.28

1.8

1.9

4.43

9.97

iu/l

0.47

358

1340

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

703

2269

1.56

24.22

1.1

15.22

11.63

au/ml

0.40

187

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

497

1469

1.70

24.19

1.1

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

103

149

3.47

23.96

6.2

4.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

493

1458

1.70

23.95

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

147

271

2.73

23.35

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

332

878

1.90

23.18

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

149

278

2.69

23.17

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

718

2353

1.54

23.16

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

333

882

1.90

23.14

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

279

2.68

23.02

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

162

318

2.56

22.91

2.2

1.8

70.82

61.47

ug/l

0.41

157

313

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

331

878

1.90

22.91

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

234

547

2.15

22.70

1.7

148.06

142.37

0.42

221

516

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

670

2173

1.55

22.64

1.2

1.1

114.92

117.66

1.35

615

1952

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

575

1799

1.61

22.59

1.5

1.4

—

(3003694) ABO and Rh group [Type] in Blood

11276

51626

1.12

22.39

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2431

9789

1.26

22.37

8.6

6.3

24.78

24.71

mmol/l

0.43

2415

9685

(3006270) Folate [Moles/volume] in Blood

393

1112

1.78

22.27

1.2

1.1

347.03

394.03

nmol/l

3.47

334

939

(3028433) Virus identified in Specimen by Culture

161

320

2.53

22.24

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

353

968

1.83

22.12

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

115

190

3.04

22.01

1.1

1.2

5.91

13.58

u/ml

0.72

134

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

239

573

2.10

21.81

1.7

1.5

1433880.33

1242353.00

iu/ml

0.11

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

201

449

2.25

21.72

1.1

1.0

—

(3016038) Potassium [Moles/volume] in Urine

291

754

1.94

21.59

1.3

1.2

35.50

35.53

mmol/l

0.01

247

660

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

4.43

21.43

1.0

1.1

0.87

0.37

u/ml

0.44

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

145

279

2.61

21.34

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

207

473

2.20

21.24

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

190

420

2.27

21.04

3.0

2.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

4.19

21.03

1.0

1.1

0.06

7.18

u/ml

0.65

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5999

26457

1.16

20.80

1.5

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

4.14

20.75

1.0

1.1

0.03

1.56

u/ml

0.84

(3024263) Appearance of Synovial fluid

247

612

2.03

20.73

1.5

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

242

595

2.04

20.73

1.4

1.2

81.00

103.78

titre

0.23

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

171

363

2.37

20.70

1.2

0.29

0.31

g/l

1.64

136

281

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

159

327

2.44

20.56

1.2

109.55

110.53

0.15

137

290

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

352

988

1.79

20.53

1.5

1.3

12.83

11.99

umol/l

1.29

328

944

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

123

221

2.80

20.52

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

250

625

2.01

20.50

1.4

1.2

385.29

515.45

titre

0.16

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

202

464

2.19

20.49

1.1

8.26

8.15

u/ml

0.01

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

101

161

3.15

20.47

1.1

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

137

262

2.63

20.42

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

102

164

3.12

20.41

2.0

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

847

2961

1.44

20.04

1.1

1.62

2.20

u/ml

1.38

470

1335

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

408

1205

1.70

20.02

1.5

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

125

3.45

19.95

1.7

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

310

844

1.85

19.92

1.7

1.4

—

(4034850) Laboratory test

1002

6849

0.73

19.91

11.2

8.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

230

564

2.05

19.87

2.3

51.65

50.86

umol/l

0.13

207

472

(1761482) Bacteria [#/volume] in Urine by Culture

994

3587

1.40

19.73

4.4

3.3

—

(3034426) Prothrombin time (PT)

189

432

2.20

19.43

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

213

512

2.09

19.38

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

393

1160

1.70

19.35

2.0

1.9

—

(40757373) Influenza virus identified in Isolate

114

203

2.82

19.34

1.6

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

512

1620

1.59

19.31

2.3

2.1

105.58

105.51

mmol/l

0.12

505

1603

(3041354) Potassium [Moles/volume] in Venous blood

512

1620

1.59

19.31

2.3

2.1

4.06

4.07

mmol/l

0.35

505

1604

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

771

2669

1.46

19.22

3.4

4.0

886.28

1073.63

u/ml

0.16

711

2445

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

147

3.18

19.13

1.2

1.1

—

(3011985) Renin [Units/volume] in Plasma

547

1764

1.56

19.04

1.5

52.13

67.88

mu/l

1.08

492

1576

(3045142) Bone marrow Pathology biopsy report

429

1305

1.65

18.92

1.4

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

111

3.53

18.66

1.1

1.3

51.97

54.25

0.11

(40768446) Kidney Pathology biopsy report

203

487

2.09

18.58

1.8

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

155

332

2.35

18.47

1.5

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

537

1738

1.56

18.43

1.5

1.3

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

5.23

18.33

1.0

2.92

2.50

u/ml

0.05

(40768441) Liver Pathology biopsy report

332

949

1.76

18.30

1.5

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

423

1295

1.64

18.22

1.2

66.03

68.80

u/l

0.20

387

1145

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

343

992

1.74

18.17

1.2

—

(3017569) Oxygen content in Arterial blood

204

495

2.07

18.16

1.8

2.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

365

1076

1.71

18.09

1.3

1.2

189.09

153.64

titre

0.11

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

342

991

1.74

18.01

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

340

984

1.74

17.98

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

251

660

1.91

17.96

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

342

992

1.73

17.94

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

499

1598

1.57

17.93

1.2

1.1

95.85

96.76

0.29

469

1500

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

365

1079

1.70

17.92

1.3

1.2

164.63

197.87

titre

0.34

169

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.79

17.91

2.1

1.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

339

982

1.74

17.87

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

516

1667

1.56

17.86

1.4

327.68

303.43

pmol/l

0.49

448

1457

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

893

3221

1.40

17.83

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

339

983

1.73

17.81

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

893

3223

1.40

17.76

1.3

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

1045

3871

1.36

17.76

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

3.72

17.76

1.0

1.1

1.38

4.09

u/ml

1.28

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

212

527

2.02

17.73

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

182

427

2.14

17.64

1.8

1.7

175.71

160.65

0.83

171

394

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

180

421

2.15

17.58

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

239

623

1.93

17.55

1.3

64.22

68.26

0.25

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

221

562

1.98

17.40

1.6

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

221

562

1.98

17.40

1.6

1.4

—

(4035726) Immunohistochemistry procedure

3149

13380

1.19

17.14

1.4

—

(3021901) Oxygen saturation in Capillary blood

743

2615

1.43

17.04

2.9

2.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

247

660

1.88

16.90

7.4

4.5

10384.88

1523.52

u/ml

0.45

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

244

650

1.89

16.84

1.5

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

223

577

1.94

16.75

1.7

2.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

159

361

2.21

16.69

1.0

11.31

11.44

u/ml

0.02

239

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

328

961

1.72

16.66

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

3.50

16.38

1.0

1.1

1.13

12.29

u/ml

1.45

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

134

285

2.36

16.28

1.5

8.63

9.23

ug/l

0.82

134

285

(3022493) Free Hemoglobin [Mass/volume] in Plasma

213

548

1.95

16.28

6.3

4.0

1139.85

4697.73

mg/l

1.42

155

371

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

211

544

1.95

16.04

1.6

1.5

3.30

5.02

nmol/l

0.69

168

455

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

4.55

16.00

1.1

27.33

16.53

0.47

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

302

876

1.73

15.92

1.5

1.4

13.24

12.43

u/l

1.04

289

851

(3033705) Calcium.ionized [Moles/volume] in Venous blood

492

1616

1.53

15.90

2.3

2.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1191

4578

1.31

15.84

1.8

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

159

370

2.16

15.78

1.1

3.35

7.55

u/ml

0.76

214

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1188

4578

1.31

15.52

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

310

913

1.71

15.51

1.3

1.2

2.08

2.26

u/ml

0.10

180

406

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

177

435

2.04

15.34

1.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.81

15.18

2.2

2.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

392

1235

1.60

15.18

4.6

5.1

63.33

92.73

u/ml

0.67

123

448

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

197

506

1.96

15.16

2.7

2.3

155.77

148.36

nmol/l

0.44

172

408

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

571

1961

1.47

14.95

1.7

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

252

708

1.79

14.82

1.2

94.21

86.06

u/l

0.51

218

615

(3009015) Lactate [Moles/volume] in Synovial fluid

3.68

14.79

1.2

1.3

4.89

5.67

mmol/l

0.50

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

132

292

2.27

14.77

2.1

1.5

41.88

34.53

u/l

0.16

122

260

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

315

946

1.67

14.71

1.9

1.7

4.46

3.86

mg/l

1.11

303

890

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

131

290

2.27

14.64

1.4

1.2

119.37

126.36

nmol/l

0.17

101

206

(3001186) Copper [Moles/volume] in Serum or Plasma

122

262

2.34

14.58

1.4

1.2

16.98

16.66

umol/l

0.29

109

231

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

255

726

1.77

14.38

1.4

1.2

5.23

5.53

umol/l

0.53

238

683

(3023323) Follitropin [Units/volume] in Serum or Plasma

1965

8120

1.22

14.31

1.4

1.3

25.15

27.35

iu/l

2.13

1669

6874

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

139

2.89

14.28

1.5

7.68

499167.84

nmol/l

1.73

119

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

156

2.77

14.27

2.0

2.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

147

348

2.12

14.05

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

234

654

1.80

14.03

1.1

1479.12

1452.99

miu/ml

0.12

234

654

(3018133) Calcium [Moles/volume] in Urine

155

2.75

13.98

2.2

1.7

2.60

2.62

mmol/l

0.02

140

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.91

13.83

7.2

4.9

—

(3051593) INR in Capillary blood by Coagulation assay

187

488

1.92

13.82

8.4

13.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

374

1194

1.58

13.76

1.4

1.3

94272.12

95127.13

e6/l

0.01

254

819

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

158

2.70

13.53

1.2

1.3

63.37

101.26

ng/l

0.58

105

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.90

13.47

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

119

2.99

13.47

1.3

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.89

13.39

12.7

10.7

161.84

214.36

e6/l

0.34

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.80

13.31

1.5

1.7

1.71

1.90

mg/l

0.08

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

630

2255

1.41

13.28

1.6

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

167

425

1.97

13.26

1.3

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

177

460

1.93

13.26

6.6

5.5

24.72

25.05

mmol/l

0.53

167

405

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

+∞

13.25

1.0

0.0

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.84

13.22

1.5

1.7

0.98

1.57

mg/l

0.42

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.84

13.22

1.5

1.7

3.04

3.12

mg/l

0.02

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.84

13.22

1.5

1.7

2.38

1.11

mg/l

0.84

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.84

13.22

1.5

1.7

2.17

2.19

mg/l

0.01

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.84

13.22

1.5

1.7

1.94

2.16

mg/l

0.11

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.84

13.22

1.5

1.7

2.08

3.83

mg/l

0.86

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.84

13.22

1.5

1.7

1.15

0.63

mg/l

0.57

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.84

13.22

1.5

1.7

1.32

2.04

mg/l

0.41

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.84

13.22

1.5

1.7

4.19

3.73

mg/l

0.15

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.27

13.20

3.1

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

163

412

1.99

13.19

1.1

91.69

92.15

0.06

185

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

133

2.83

12.98

1.1

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

274

822

1.68

12.92

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

185

497

1.87

12.61

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

237

688

1.73

12.59

1.2

23.17

24.15

u/l

0.08

201

590

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.38

12.50

3.1

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

208

2.39

12.47

1.6

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

262

785

1.68

12.44

1.2

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

154

2.64

12.41

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

732

2721

1.35

12.33

3.3

2.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

109

241

2.27

12.30

1.4

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

194

2.43

12.29

1.4

1.3

56.64

65.35

mu/l

0.23

151

(40765096) Chromosome analysis panel by Banding

127

300

2.13

12.28

1.1

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

160

414

1.94

12.18

1.1

1.2

107.26

106.70

0.05

144

376

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

124

2.83

12.17

1.1

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

147

2.66

12.16

1.9

1.4

131.85

121.74

ng/l

0.20

147

(3008536) Aspergillus sp Ab [Presence] in Serum

183

2.47

12.13

2.5

2.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

634

2310

1.38

12.10

1.0

1.1

2.89

2.81

u/ml

0.06

283

1325

(3020911) Cortisol [Moles/time] in 24 hour Urine

158

408

1.94

12.10

1.4

1.3

102.67

307.43

nmol/24h

1.34

158

408

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.10

12.09

1.1

—

(3016228) CD19 cells/100 cells in Blood

189

519

1.83

12.07

2.2

1.9

8.08

7.90

0.07

179

508

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

294

918

1.61

11.93

1.1

1.2

1.05

1.07

ratio

1.04

424

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

143

2.67

11.89

1.9

2.0

1.20

1.56

mmol/l

0.50

112

(1002224) Polysomnography panel

1810

7567

1.21

11.77

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

447

1537

1.46

11.76

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

155

402

1.94

11.74

1.1

1.2

89.95

92.50

0.27

184

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

187

2.42

11.63

1.5

1.4

0.39

0.46

ug/l

0.49

124

(21491868) Cryoglobulin [Mass/volume] in Serum

165

439

1.89

11.62

1.2

1.1

0.23

g/l

0.00

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

251

2.20

11.58

1.1

—

(3021788) Differential panel - Synovial fluid

708

2646

1.35

11.55

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

2.89

11.55

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

128

2.74

11.54

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

960

6111

0.78

11.48

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

295

933

1.59

11.39

1.6

1.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

161

429

1.88

11.30

2.3

2.6

1.02

1.20

ug/l

0.45

149

401

(3044941) Cell count panel - Synovial fluid

603

2206

1.38

11.27

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

127

2.73

11.26

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

711

2672

1.34

11.20

1.2

—

(3020491) Glucose [Moles/volume] in Blood

334

1092

1.54

11.20

1.7

1.9

6.28

6.71

mmol/l

2.27

226

881

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

103

232

2.23

11.19

1.3

24.33

21.92

0.35

190

(3009871) Measles virus Ab [Titer] in Serum

168

456

1.85

11.16

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

191

2.37

11.15

1.1

0.70

0.96

umol/24h

0.38

(3051651) Icteric interference index of Serum or Plasma

259

800

1.63

11.02

4.1

3.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

125

307

2.04

11.01

1.2

39.48

40.83

g/l

0.44

167

(3023420) DNA double strand Ab [Units/volume] in Serum

448

1562

1.44

11.01

1.6

1.5

25.52

30.58

iu/ml

0.45

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

4.06

11.00

1.0

1.1

11.47

23.36

u/ml

0.49

(3020393) Adenovirus Ag [Presence] in Stool

106

2.89

10.99

1.3

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

688

2582

1.34

10.95

1.1

1.0

3.32

4.47

u/ml

1.32

349

1151

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

133

2.64

10.80

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

159

430

1.86

10.71

2.4

1.6

5313.15

2771.65

e6/l

0.22

117

265

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

573

2102

1.37

10.57

1.1

1.0

0.41

0.55

u/ml

0.37

184

435

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

183

521

1.76

10.48

2.9

2.3

93.81

147.06

au/ml

0.70

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3586

20170

0.88

10.45

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

133

2.60

10.38

1.5

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

623

2323

1.35

10.38

2.3

2.2

7.52

6.24

umol/l

0.56

441

1702

(21494814) CD8 cells/100 lymphocytes in Specimen

179

508

1.77

10.36

2.3

1.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.46

10.32

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

450

1591

1.42

10.30

1.5

1.4

2944.70

2514.21

e6/l

0.37

343

1086

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

137

2.56

10.24

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

233

715

1.64

10.21

1.1

1.2

20.78

20.23

u/ml

0.01

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.40

10.18

1.2

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

209

624

1.68

10.16

1.1

88.81

83.19

u/l

0.34

196

546

(44813793) Dust mix specific IgE antibody measurement

313

1032

1.52

10.16

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

205

609

1.69

10.15

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

225

687

1.65

10.06

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

258

816

1.59

10.03

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

282

915

1.55

9.85

1.1

7.69

9.25

iu/ml

0.50

273

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

207

622

1.67

9.85

1.1

26.89

22.43

u/l

0.50

192

550

(3051611) Lipemic interference index of Serum or Plasma

409

1434

1.43

9.82

3.6

3.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

143

385

1.86

9.81

1.6

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

500

1819

1.38

9.75

1.5

1.4

32.19

33.67

g/l

1.73

448

1639

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

101

240

2.11

9.73

1.2

228.18

332.68

pmol/l

2.28

183

(3043410) Blood group antigens tested for on Red Blood Cells

136

362

1.89

9.66

1.5

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

484

1755

1.39

9.63

1.5

58.69

57.25

0.31

312

1097

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

175

505

1.74

9.62

2.1

1.8

9.10

9.64

mg/l

0.56

146

383

(3011897) Casein IgE Ab [Units/volume] in Serum

189

2.26

9.58

1.2

1.3

0.88

2.52

u/ml

0.94

184

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

469

1693

1.39

9.58

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

121

2.61

9.58

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

199

2.22

9.55

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

198

593

1.68

9.55

1.3

1.2

163.82

167.00

mmol/24h

0.18

198

593

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

248

788

1.58

9.49

1.5

6.64

6.31

u/l

0.14

203

595

(43055514) Macroprolactin [Presence] in Serum or Plasma

137

368

1.87

9.48

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

226

2.13

9.48

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

109

270

2.03

9.47

1.2

73.84

78.58

0.32

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

207

629

1.65

9.46

2.1

2.3

172.03

178.09

ug/l

0.01

189

598

(3005033) Fetal Nuchal fold Thickness US

827

5226

0.79

9.38

1.4

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

127

334

1.91

9.36

1.3

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

250

799

1.57

9.35

6.3

7.2

—

(3014891) Appearance of Pleural fluid

138

2.47

9.31

1.2

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

101

245

2.07

9.27

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

101

245

2.07

9.27

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

101

245

2.07

9.27

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

101

245

2.07

9.27

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

3.08

9.24

1.0

2.89

0.93

u/ml

0.44

(3034092) Cytoplasmic Ig cells/100 cells in Blood

148

2.41

9.22

6.0

6.1

—

(3007463) Buprenorphine [Presence] in Urine

3.79

9.12

5.8

12.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

165

2.31

9.06

2.2

1.5

49.73

55.03

pmol/l

0.14

137

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

289

962

1.51

9.04

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.85

9.03

3.4

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

853

5346

0.80

9.02

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

102

252

2.03

8.95

6.9

5.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

834

5235

0.80

8.94

1.4

1.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

3.05

8.93

1.0

1.1

8.73

8.52

u/ml

0.02

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.95

8.84

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

108

274

1.98

8.83

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

191

580

1.65

8.79

3.6

2.9

7.62

8.51

mg/l

1.11

156

436

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

228

724

1.58

8.79

1.7

2.79

2.40

u/field

0.18

162

574

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

207

642

1.62

8.79

2.0

2.2

104.00

130.84

ug/min

0.18

123

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

345

1198

1.45

8.78

1.4

1.3

362.74

510.39

u/l

1.83

329

1135

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1561

6621

1.19

8.77

1.7

1.6

4.47

3.69

mg/l

1.48

1170

4509

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

171

505

1.70

8.73

1.4

74.36

72.62

0.86

166

485

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.96

8.71

1.3

1.1

15.78

13.40

nmol/l

0.33

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

167

491

1.71

8.66

1.4

421.76

884.74

mu/l

1.27

162

471

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4488

20477

1.11

8.66

1.5

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

195

2.16

8.62

1.3

1.2

77.17

186.10

titre

0.70

(3007916) DNA double strand Ab [Titer] in Serum

111

2.58

8.49

1.4

152.00

59.59

titre

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

118

2.51

8.36

1.3

1.2

555.18

76.51

u/l

0.50

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.84

8.34

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

154

448

1.73

8.31

2.8

28.58

28.43

umol/l

0.06

106

340

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2404

13658

0.88

8.21

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

325

1134

1.44

8.11

2.0

2.12

2.01

u/field

0.10

144

462

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.52

8.09

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

132

370

1.79

8.08

1.1

—

(3004775) Volume in Urine collected for unspecified duration

326

1139

1.44

8.08

2.4

1.9

633.79

701.10

2.19

230

706

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

788

3146

1.26

8.05

1.7

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

191

2.13

8.04

7.2

6.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

688

2703

1.28

8.01

1.5

1.4

0.38

0.43

nmol/l

0.48

553

2150

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

209

668

1.57

7.90

1.1

96.42

95.99

0.06

169

515

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

770

4802

0.80

7.85

1.5

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

167

506

1.66

7.82

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

129

2.37

7.75

3.7

7.0

65.17

65.27

g/mol

0.00

124

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

181

2.13

7.72

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

105

2.53

7.68

1.3

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

105

278

1.90

7.68

1.2

77.26

87.49

1.24

(3035947) Staphylolysin Ab [Units/volume] in Serum

212

685

1.55

7.67

1.1

3.36

4.28

iu/ml

0.57

(3036603) Volume of Urine

267

907

1.48

7.67

1.5

1.6

2011.35

1938.46

0.60

262

892

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

195

2.08

7.66

1.7

1.3

0.25

nmol/l

0.00

130

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

198

630

1.58

7.65

3.6

3.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1713

7411

1.16

7.62

3.0

3.3

45.02

50.89

u/ml

0.57

1655

7179

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

251

843

1.50

7.62

1.3

1.4

5.64

5.54

mmol/l

0.73

234

795

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

193

611

1.59

7.61

4.3

3.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

193

612

1.58

7.57

1.2

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

144

423

1.71

7.56

1.2

1.3

22.11

20.23

0.10

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.80

7.49

1.6

46.56

43.29

umol/l

0.23

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

125

2.37

7.49

11.9

7.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

112

306

1.84

7.47

6.7

6.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

118

328

1.81

7.46

1.3

31.79

38.68

1.08

237

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

154

2.22

7.46

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.86

7.39

2.7

2.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

163

499

1.64

7.37

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

137

401

1.72

7.30

1.8

1.6

152.18

140.54

au/ml

0.08

(3024869) Neuronal Ab [Presence] in Serum

189

2.07

7.28

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.06

7.25

1.8

1.9

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

150

2.21

7.20

3.3

2.8

38.71

45.90

umol/l

1.47

130

(3013727) Leukocytes other/100 leukocytes in Blood

147

442

1.67

7.13

3.8

3.3

54.34

52.53

0.38

142

427

(3016750) Collection duration of Urine

247

840

1.48

7.09

2.2

1.9

497.93

502.25

min

0.29

196

564

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

175

2.09

7.02

1.1

5.35

12.38

pmol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

625

2472

1.27

6.97

1.1

1.0

4.53

5.77

u/ml

0.79

274

985

(3027231) Wheat IgE Ab [Units/volume] in Serum

263

1.87

6.94

1.1

3.92

0.78

u/ml

0.59

249

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

616

2438

1.27

6.84

1.3

6.95

6.94

mmol/l

0.02

541

2173

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

135

402

1.69

6.80

2.2

1.5

18940.10

10548.38

e6/l

0.27

191

(3047189) Immunofixation for 24 hour Urine

175

559

1.57

6.71

1.6

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

113

2.35

6.68

1.0

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2941

13304

1.12

6.68

3.9

3.7

1.23

1.22

mmol/l

0.59

2631

11316

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

260

1.85

6.63

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

101

2.43

6.62

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4326

19988

1.09

6.44

1.7

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

109

2.35

6.41

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.96

6.33

1.2

1.1

34.25

15.75

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.96

6.33

1.2

1.1

25.10

20.94

u/ml

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.78

6.24

1.1

1.75

4.40

u/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

883

3675

1.21

6.23

1.2

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

132

402

1.65

6.17

1.2

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.29

6.16

1.4

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

392

1487

1.32

6.05

1.5

1.4

68416.44

50346.62

e6/l

0.49

247

830

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.85

6.00

3.5

4.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

156

2.06

5.97

1.2

1.3

31.87

48.31

mg/l

2.11

131

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.54

5.92

1.1

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.90

5.92

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.61

5.78

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

135

2.12

5.72

1.0

0.01

0.69

u/ml

1.31

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

106

2.27

5.67

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

275

1.75

5.62

2.5

2.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

792

3305

1.20

5.50

1.5

1.4

145.10

129.38

pmol/l

0.28

772

3240

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

2.18

5.40

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

260

1.76

5.39

1.3

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

265

965

1.38

5.38

1.3

14.48

14.33

u/l

0.03

243

910

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

153

2.00

5.32

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

321

1207

1.34

5.32

1.8

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

185

1.90

5.29

1.6

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

140

2.04

5.26

1.2

—

(40758292) HTLV I+II Ab panel - Serum

229

1.80

5.25

1.4

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

4.46

5.24

1.3

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.30

5.24

8.5

7.9

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

274

1.72

5.22

1.4

1.2

25.36

47.96

g/l

0.57

222

(3006184) Hemoglobin [Mass/volume] in Capillary blood

865

3661

1.19

5.17

2.2

130.62

131.42

g/l

0.38

602

2857

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

104

314

1.66

5.10

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

106

322

1.65

5.09

1.6

1.2

12.92

13.37

g/l

0.18

245

(3002523) Influenza virus A Ag [Presence] in Specimen

745

3117

1.20

5.07

1.1

—

(3044007) Cell count panel - Peritoneal fluid

122

385

1.59

5.05

2.2

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

112

2.15

5.04

1.4

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

157

1.95

4.99

2.2

1.5

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.55

4.96

1.2

1.4

35.74

35.56

0.01

(3030313) Adrenal Ab [Titer] in Serum

103

2.19

4.95

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

113

2.13

4.94

3.2

2.1

—

(3045788) Cell count panel - Pleural fluid

339

1300

1.31

4.94

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

743

3118

1.20

4.91

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

166

566

1.47

4.87

1.1

—

(3019174) dRVVT (LA screen)

102

2.16

4.72

1.3

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

102

2.16

4.72

1.3

1.2

706.74

219.10

mg/24h

—

(40768806) Pleura Pathology biopsy report

382

1499

1.28

4.71

1.6

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

231

843

1.38

4.69

1.3

1.2

322.66

389.58

u/l

0.37

211

797

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.30

4.66

1.2

1.3

0.89

1.27

ml/s/173m2

1.59

(3013336) Amino acids [Identifier] in Serum or Plasma

3.61

4.65

3.6

2.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

130

2.01

4.63

2.6

3.0

0.62

0.49

u/field

0.39

130

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2102

11623

0.90

4.62

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.37

4.60

1.3

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

209

753

1.39

4.59

1.2

1.1

168.54

216.17

iu/ml

1.76

209

743

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

443

1777

1.25

4.57

1.8

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

293

1116

1.32

4.53

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

163

1.88

4.52

2.4

2.5

83.99

68.75

pmol/l

0.27

146

(3036782) Glucose [Moles/volume] in Pleural fluid

350

1367

1.29

4.50

1.4

1.3

6.31

6.08

mmol/l

0.77

323

1261

(3026470) Cobalt [Mass/volume] in Blood

212

771

1.38

4.43

2.0

2.60

3.53

ug/l

1.96

195

709

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

138

464

1.49

4.38

2.1

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

936

5417

0.86

4.36

1.7

1.8

—

(3020650) Glucose [Presence] in Urine

638

0.61

4.34

1.5

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.96

4.34

4.1

3.4

—

(3042631) Mycobacterium sp identified in Specimen

485

1978

1.23

4.33

3.1

2.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.19

4.23

1.0

1.37

1.17

u/ml

0.10

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.01

4.23

1.2

1.4

—

(3012441) Differential panel - Pleural fluid

373

1482

1.26

4.21

1.5

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.33

4.21

1.3

1.4

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.47

4.14

1.1

1.4

13.22

14.58

0.09

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

851

3671

1.17

4.14

1.7

1.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

122

1.97

4.13

1.3

1.1

11.40

8.93

mg/l

0.59

115

(3013247) Albumin in CSF/Albumin in Serum or Plasma

100

318

1.58

4.09

1.1

6.87

6.16

mg/g

0.43

305

(40763590) HLA-DQ beta [Type]

3.22

4.02

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.07

3.96

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

206

761

1.36

3.96

2.0

2.1

1.94

2.32

ug/l

1.01

171

659

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.29

3.96

1.0

1.1

0.56

4.18

u/ml

1.53

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.38

3.90

3.5

3.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

493

2977

0.83

3.89

1.2

—

(3013862) HLA-DP [Type]

3.11

3.83

1.0

—

(3006462) Nitrate [Presence] in Urine

191

702

1.37

3.81

3.6

2.5

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.01

3.78

5.9

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

132

455

1.46

3.77

3.3

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

132

455

1.46

3.77

3.3

2.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

225

1.65

3.66

3.0

1853.64

1729.94

u/l

0.04

206

(40760409) HLA-A [Type] by High resolution

3.01

3.65

1.0

—

(40760410) HLA-B [Type] by High resolution

3.01

3.65

1.0

—

(46236302) HLA-C [Type] by High resolution typing

3.01

3.65

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.01

3.65

1.2

1.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

214

1.66

3.63

1.0

81.16

77.43

ug/l

0.34

180

(3017509) Phencyclidine [Presence] in Urine

195

1.70

3.62

1.7

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

103

341

1.52

3.59

1.2

371.81

190.40

ug/l

0.29

178

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.70

3.58

1.6

1.4

—

(3033799) Differential panel - Peritoneal fluid

122

419

1.46

3.57

2.1

1.7

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.17

3.53

1.3

1.1

2.76

3.33

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

286

1129

1.27

3.49

1.1

2.64

4.33

u/ml

0.25

264

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.37

3.48

1.6

29.25

17.89

nmol/l

0.43

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

102

1.97

3.47

1.1

1.2

1.74

1.70

umol/24h

0.08

102

(3042951) Complement C1q Ab [Units/volume] in Serum

2.46

3.45

1.0

1.2

26.50

24.71

u/ml

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.07

3.44

1.4

—

14.32

—

(3034614) HLA Ag [Interpretation]

3.09

3.38

1.3

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

188

1.68

3.37

1.6

1.5

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.18

3.36

2.5

2.9

21.93

59.98

pmol/l

0.34

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

310

1.52

3.36

1.3

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

143

1.79

3.36

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

747

4303

0.87

3.36

3.5

3.0

27.17

27.61

mg/l

0.11

443

2836

(40762814) Titanium [Mass/volume] in Blood

181

1.69

3.33

2.3

2.4

3.95

3.97

ug/l

0.01

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.34

3.31

2.3

1.3

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

167

1.71

3.26

1.8

1.7

1.54

1.84

mg/l

0.72

137

(3002619) Bacteria identified in Specimen by Culture

289

1.53

3.23

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

163

1091

0.75

3.21

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

120

1.84

3.18

1.3

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

150

548

1.37

3.18

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

161

1.71

3.17

1.5

1.6

127.65

110.76

ug/l

0.51

129

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.93

3.14

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

283

1.52

3.14

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

283

1133

1.25

3.12

1.1

2.45

2.16

u/ml

0.08

106

328

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.31

3.09

1.0

1.1

7.94

8.77

mmol/l

1.57

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

114

1.85

3.09

1.3

1.2

44.12

48.43

mg/l

0.40

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

285

1.51

3.05

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

285

1.51

3.05

1.2

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

4.56

3.02

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.76

3.01

8.0

3.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.58

3.01

1.1

5.99

4.84

mmol/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

267

1665

0.80

3.01

1.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

250

1.55

3.00

1.4

1.9

1.95

4.54

ug/l

0.79

164

(3032868) Hemoglobin electrophoresis panel in Blood

145

1.73

2.99

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

149

1.72

2.98

1.3

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

143

525

1.37

2.97

1.2

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.08

2.94

1.0

49.09

48.95

u/l

0.00

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

204

791

1.29

2.93

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

134

488

1.38

2.93

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.73

2.91

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

154

1.69

2.90

2.7

2.5

—

(3000285) Sodium [Moles/volume] in Blood

154

1.69

2.90

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.10

2.90

1.2

1.4

—

(3019977) pH of Arterial blood

220

863

1.28

2.90

2.7

2.4

7.42

0.25

356

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.77

2.88

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.58

2.87

5.5

0.94

1.70

mg/l

0.95

(3018001) Oat IgE Ab [Units/volume] in Serum

2.05

2.85

1.0

0.22

0.30

u/ml

0.19

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

294

1.48

2.84

1.2

148.50

35.72

mg/l

0.79

217

(3033942) Copper [Moles/time] in 24 hour Urine

2.34

2.79

1.0

1.1

0.60

0.42

umol/24h

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.97

2.75

1.1

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

3.68

2.75

1.2

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

4.51

2.74

1.1

1.24

1.22

mg/l

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.51

2.73

1.0

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

2.22

2.73

1.1

0.03

0.89

mg/l

0.52

(3052592) Norovirus Ag [Presence] in Stool

244

1.52

2.72

1.5

1.3

—

(3035880) pH of Pleural fluid

196

765

1.29

2.71

1.4

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

127

1.74

2.71

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.34

2.70

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.25

2.70

1.5

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.90

2.68

1.5

1.2

316.27

317.94

umol/24h

0.02

(3027696) Helicobacter pylori Ab [Titer] in Serum

5.01

2.67

1.1

1.0

1466.25

1243.75

titre

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.44

2.61

1.2

1.0

255.09

221.25

pmol/l

0.11

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1580

7291

1.09

2.60

1.9

1.8

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

116

422

1.38

2.59

1.3

55.94

56.80

0.08

363

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.02

2.58

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

108

389

1.39

2.56

1.3

1.2

3.67

3.73

mmol/l

0.06

101

358

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

343

1.42

2.55

1.2

—

(3049233) Organic acids panel - Urine

4.10

2.55

1.1

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.86

2.53

1.2

1.6

9.10

9.71

u/ml

0.02

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.14

2.52

1.1

1.3

0.67

0.98

0.31

(3007542) Rye IgE Ab [Units/volume] in Serum

1.99

2.50

1.0

1.47

0.26

u/ml

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.81

2.48

1.2

1.1

10.83

12.54

u/l

0.20

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.01

2.48

1.6

2.6

4.38

1.69

mu/l

0.73

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

4.46

2.47

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

144

1.64

2.38

1.5

1.4

72.51

70.06

0.22

117

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.31

2.36

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

200

1.53

2.35

1.6

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

137

521

1.32

2.34

1.5

1.4

63.11

62.47

0.07

109

441

(3008343) Lysozyme [Mass/volume] in Urine

6.02

2.34

1.0

0.43

27.20

mg/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

374

1592

1.18

2.33

1.6

7.82

7.54

mmol/l

1.47

350

1533

(3050794) Legionella sp Ab [Presence] in Serum

123

1.67

2.26

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

2.11

2.25

1.0

1.1

—

(3013762) Body weight Measured

2.13

2.22

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

179

1.54

2.21

1.3

1.2

1.43

1.54

mmol/l

0.05

107

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3491

18377

0.95

2.21

3.5

3.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

101

1.74

2.21

5.3

4.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.36

2.20

1.0

—

(3022670) pH of Venous cord blood

2.17

2.18

1.1

1.0

—

(3000012) Reticulocyte production index

507

2229

1.14

2.11

2.1

2.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

5.01

2.11

1.0

236.67

298.00

nmol/l

—

(1616796) Gas panel - Central venous blood

846

3836

1.11

2.09

3.8

3.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

138

1.60

2.08

5.1

2.4

0.93

1.32

mg/l

1.13

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

107

1.69

2.07

1.2

137.72

111.10

ug/l

0.32

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.87

2.00

1.4

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.80

2.00

1.3

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.99

1.98

5.5

4.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

247

1.42

1.95

1.3

1.2

1.63

1.66

mmol/l

0.07

142

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

270

1139

1.19

1.94

1.2

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.34

1.91

1.0

0.26

0.07

u/ml

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

2.13

1.90

1.0

0.11

0.03

u/ml

—

(40759632) Porphyrins [Mass/mass] in Stool

4.30

1.90

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

150

1.54

1.88

1.4

1.5

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.51

1.84

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

382

1666

1.15

1.83

1.4

1.3

195.46

199.37

pmol/l

0.05

382

1666

(3024316) Viscosity of Plasma

1.79

1.78

1.5

1.9

1.62

1.97

mpas

0.95

(3035320) C reactive protein [Mass/volume] in Body fluid

279

1191

1.18

1.78

2.6

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

525

2344

1.12

1.77

1.3

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.33

1.77

9.6

9.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.76

1.77

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.41

1.74

1.2

1.1

2.75

2.36

0.26

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

203

1.43

1.72

3.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

161

655

1.23

1.71

1.0

—

(3041184) Isoniazid [Presence] in Urine

3.19

1.69

3.0

2.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1107

5980

0.93

1.66

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

135

542

1.25

1.63

1.4

1.8

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

2.51

1.63

1.1

37.92

33.95

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1111

5994

0.93

1.62

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1110

5988

0.93

1.62

1.4

1.5

—

(3012501) Base excess in Blood by calculation

809

4417

0.92

1.59

4.3

3.7

2.40

2.49

mmol/l

0.44

548

2964

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

120

1.55

1.59

1.1

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.69

1.57

1.7

1.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.34

1.57

1.2

1.0

—

(3013290) Carbon dioxide [Partial pressure] in Blood

810

4417

0.92

1.56

4.3

3.7

5.03

5.00

kpa

0.61

793

4318

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1107

5956

0.93

1.52

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.65

1.51

1.7

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

105

414

1.27

1.50

1.1

1.2

—

(3004451) EKG impression Narrative

185

776

1.20

1.49

1.3

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.79

1.46

1.1

1.0

2.14

0.17

u/ml

0.73

(3027315) Oxygen [Partial pressure] in Blood

815

4427

0.92

1.45

4.3

3.7

8.72

8.65

kpa

0.48

797

4328

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.10

1.45

1.0

1.1

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

3.58

1.44

1.0

11.67

2.58

u/ml

—

(46235168) Fasting glucose [Moles/volume] in Blood

233

1.36

1.42

1.4

2.2

8.40

7.01

mmol/l

1.33

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

242

1.35

1.41

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

245

1060

1.16

1.39

1.0

1.60

0.76

u/ml

0.35

219

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.81

1.36

1.3

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.63

1.35

2.7

1.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.26

1.34

1.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.51

1.32

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.51

1.32

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.51

1.32

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.51

1.32

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.51

1.32

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.51

1.32

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

232

1.34

1.32

1.6

1.4

8.79

10.43

0.31

134

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.95

1.31

2.1

2.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.55

1.29

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

159

670

1.19

1.27

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.12

1.26

1.3

1.2

1.90

2.23

mmol/24h

0.28

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.56

1.24

1.1

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

135

0.59

1.22

1.8

1.9

16.91

19.43

0.11

(4212803) Bone marrow aspirate examination

125

1.44

1.19

1.1

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.74

1.17

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

331

1486

1.12

1.14

1.5

28.15

31.60

0.96

211

921

(40758358) Immune stain study

1.74

1.12

1.0

—

(3032641) Amino acids panel - Urine

2.34

1.11

1.6

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

275

1.28

1.10

2.7

2.4

48.69

30.58

mg/l

0.29

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.15

1.10

2.2

—

(3015183) Erythrocyte sedimentation rate

220

968

1.14

1.06

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

137

1.39

1.06

1.2

1.1

21.22

19.95

u/l

0.10

(40761539) Cells [Type] in Urine sediment by Light microscopy

395

1.22

1.03

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

729

3910

0.93

1.02

3.8

3.2

4.04

4.15

e9/l

0.68

729

3904

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.76

1.01

1.1

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

186

1.32

1.01

1.3

1.4

35.45

24.08

1.01

142

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

486

2242

1.09

1.00

3.9

3.3

24.15

41.96

u/ml

4.30

472

2158

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.71

1.00

1.2

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

115

683

0.84

0.99

6.2

6.5

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.06

0.99

1.1

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

2.06

0.99

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1206

6357

0.95

0.96

1.5

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.71

0.94

1.1

1.0

0.19

0.06

u/ml

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.71

0.94

1.1

208.43

271.42

nmol/l

0.64

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.46

0.94

1.0

173.00

166.02

g/l

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.93

0.94

1.2

1.0

73.07

65.24

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

545

2942

0.93

0.94

2.6

2.2

13.17

13.11

0.90

539

2896

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

202

1.29

0.93

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

116

683

0.85

0.92

3.1

3.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

154

0.68

0.91

1.9

2.0

59.56

56.68

0.14

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.77

0.90

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

431

1993

1.09

0.88

22.3

6.1

7.55

7.10

mmol/l

1.34

346

1639

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.48

0.84

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

175

991

0.88

0.83

1.6

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

357

1.19

0.80

3.1

2.2

158.46

93.66

ng/l

0.74

163

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.74

0.77

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

1.72

0.77

7.1

5.6

—

(40768800) Prostate Pathology biopsy report

674

3188

1.06

0.76

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

119

517

1.15

0.76

1.1

1.0

—

(3008607) Semen analysis panel

164

1.28

0.76

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.75

0.71

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

325

1764

0.92

0.71

1.2

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.67

0.70

1.1

1.0

0.01

0.06

u/ml

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

100

1.35

0.70

6.4

2.1

6.36

16.30

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

230

1.22

0.68

1.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

556

2957

0.94

0.68

2.0

1.7

1.71

1.78

mmol/l

0.82

543

2892

(3001218) Citrate [Mass/time] in 24 hour Urine

1.67

0.67

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

305

0.82

0.65

6.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.64

0.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

363

1697

1.07

0.63

1.3

1.4

8.87

7.87

mmol/l

4.13

350

1633

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.63

0.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

139

1.26

0.59

1.1

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

256

1.18

0.53

4.8

4.6

44.40

50.95

ug/min

0.31

211

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.34

0.50

1.2

1.0

35.93

36.32

0.11

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.34

0.50

1.2

1.0

20.16

21.65

0.87

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.34

0.50

1.1

1.0

8.31

8.69

0.24

(3022806) Fractional oxyhemoglobin in Capillary blood

455

2401

0.95

0.49

2.0

1.7

90.16

89.63

1.28

448

2364

(3032743) Legionella sp IgG Ab [Presence] in Serum

107

1.27

0.48

1.0

1.1

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.43

0.0

1.3

—

1.38

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

0.43

0.0

1.1

—

5.50

—

(3018291) Platelet Ab [Presence] in Serum

1.43

0.43

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1470

7185

1.03

0.43

1.5

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

225

1.16

0.42

1.2

1.3

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

142

1.20

0.41

1.2

1.6

0.12

0.24

umol/l

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.40

0.40

1.4

1.3

650.77

491.18

nmol/l

0.31

(40768795) Lymph node Pathology biopsy report

318

1682

0.95

0.40

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.29

0.39

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

294

1.13

0.37

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

190

1016

0.94

0.36

1.7

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

112

1.21

0.36

1.0

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.37

0.35

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

247

1172

1.06

0.35

2.0

1.7

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.34

0.33

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

111

0.81

0.31

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

216

1142

0.95

0.30

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

230

1096

1.05

0.30

1.6

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

110

1.19

0.30

1.0

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

164

0.86

0.30

1.1

17.10

17.69

g/l

0.14

147

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.78

0.29

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

192

1016

0.95

0.29

1.7

1.4

—

(3040794) Aluminum [Moles/volume] in Urine

1.25

0.28

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

191

1.13

0.28

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.19

0.27

1.4

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.25

0.26

6.9

5.8

0.32

0.22

mmol/l

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.18

0.25

1.1

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.28

0.24

1.1

1.3

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

105

495

1.06

0.22

1.6

1.4

2.70

2.46

0.10

423

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.25

0.20

1.3

1.0

—

mmol/l

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.20

0.20

1.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.20

0.20

1.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

426

1.06

0.18

1.6

1.3

22.36

22.34

0.00

388

(3001019) Free T4 and TSH panel - Serum or Plasma

2110

10471

1.01

0.17

1.7

1.6

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.72

0.17

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

221

1146

0.97

0.17

1.4

30.58

32.99

nmol/l

0.60

196

1071

(40767503) Oxygen content in Capillary blood by calculation

755

3850

0.98

0.17

2.7

2.3

16.57

16.61

0.08

415

1777

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.15

0.17

1.1

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.84

0.16

1.4

1.5

1.00

1.13

u/field

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.14

0.16

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

275

1416

0.97

0.15

1.7

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

113

1.11

0.14

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.86

0.13

1.3

1.2

3160.57

2438.56

ng/l

—

(3009677) Dengue virus Ab [Presence] in Serum

1.14

0.12

1.1

—

(3012565) Volume of 24 hour Urine

178

916

0.97

0.11

2.3

2.2

1957.57

2000.74

0.21

155

834

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.14

0.10

1.0

1.1

—

(3001729) Color of Synovial fluid

135

1.08

0.10

1.5

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

197

0.94

0.09

2.7

2.5

—

(36303858) Crystals [Presence] in Urine

1.16

0.09

1.2

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

219

1.05

0.09

1.2

19.83

20.44

mmol/l

0.40

181

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1182

5885

1.01

0.08

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

287

1461

0.98

0.08

1.6

1.3

0.96

0.95

g/l

0.15

287

1453

(40768793) Breast Pathology biopsy report

671

3338

1.01

0.06

1.4

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

116

594

0.98

0.06

2.9

3.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

739

3731

0.99

0.06

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

247

1253

0.99

0.05

1.3

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

134

1.05

0.04

1.0

1.1

7.71

16.20

iu/ml

—

(3011325) HIV 1+2 Ab [Presence] in Serum

101

0.94

0.04

1.1

1.0

—

(3025130) Human papilloma virus identified in Specimen

476

2398

1.00

0.03

1.8

1.7

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

332

0.98

0.02

1.9

2.7

8.00

7.22

mmol/l

0.59

165

(3034891) Synovial lining cells/100 cells in Synovial fluid

158

798

0.99

0.01

1.4

3.62

4.25

0.21

205

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

275

0.98

0.01

1.1

1.2

—

(3010421) pH of Blood

982

4929

1.00

0.01

4.2

3.6

7.42

1.22

856

4650

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.99

0.00

1.1

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

152

0.99

0.00

1.0

12.09

9.04

mu/l

1.15

120

(3021706) Oxygen [Partial pressure] in Arterial cord blood

143

1.02

0.00

1.1

1.0

3.05

3.66

kpa

0.81

120

(3004959) Base excess in Arterial cord blood by calculation

143

1.02

0.00

1.0

-1.92

-1.91

mmol/l

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

146

1.00

0.00

1.1

1.0

7.40

7.36

kpa

0.05

124

(3035611) Eosinophils/100 leukocytes in Synovial fluid

121

0.99

0.00

1.6

1.7

0.82

0.65

0.11

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.96

0.00

1.0

1.1

—

(3006598) pH of Arterial cord blood

147

0.99

0.00

1.1

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

563

2824

1.00

0.00

1.4

1.3

4.20

4.06

ug/l

0.06

509

2568

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

118

1.02

0.00

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.00

-0.00

1.2

1.0

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

12.46

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.8

—

3.40

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES – Persons encountering health services for examination and investigation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Persons encountering health services for examination and investigation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Persons encountering health services for examination and investigation (Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints